{
  "drug": {
    "id": "DB12530",
    "name": "Inebilizumab",
    "type": "drug",
    "primary_target": "CD19",
    "moa": "B-cell depletion via anti-CD19 antibody"
  },
  "focus": "B-cell/CD19 mechanism",
  "statistics": {
    "total_paths": 59,
    "unique_diseases": 46,
    "avg_attention": 0.6196192707013869,
    "avg_combined_score": 0.36217404515809476,
    "paths_by_type": {
      "B_cell_protein_network": 44,
      "B_cell_disease": 11,
      "CD19_direct_target": 4
    },
    "paths_by_relevance": {
      "HIGH": 48,
      "MEDIUM-HIGH": 11
    }
  },
  "path_types": {
    "CD19_direct_target": "Disease directly linked to CD19 gene",
    "B_cell_pathway": "Disease linked via B-cell signaling pathway",
    "B_cell_protein_network": "Disease linked via B-cell protein interactions",
    "CD19_drug_similarity": "Disease treated by other CD19-targeting drugs",
    "B_cell_disease": "B-cell related disease"
  },
  "global_top_paths": [
    {
      "hops": 3,
      "path_type": "B_cell_protein_network",
      "mechanism": "CD19 interacts with CD79A (B-cell protein), which is associated with this disease",
      "nodes": [
        {
          "idx": 19645,
          "name": "Inebilizumab",
          "type": "drug"
        },
        {
          "idx": 6067,
          "name": "CD19",
          "type": "gene/protein",
          "role": "PRIMARY_TARGET"
        },
        {
          "idx": 440,
          "name": "CD79A",
          "type": "gene/protein",
          "role": "B_CELL_MARKER"
        },
        {
          "idx": 83796,
          "name": "lymphosarcoma",
          "type": "disease"
        }
      ],
      "attention_scores": [
        0.48622123524546623,
        0.9040263593196869,
        0.5310772471129894
      ],
      "avg_attention": 0.6404416138927141,
      "combined_score": 0.3697591381811969,
      "disease_name": "lymphosarcoma",
      "clinical_relevance": "HIGH - Through B-cell protein network"
    },
    {
      "hops": 3,
      "path_type": "B_cell_protein_network",
      "mechanism": "CD19 interacts with SYK (B-cell protein), which is associated with this disease",
      "nodes": [
        {
          "idx": 19645,
          "name": "Inebilizumab",
          "type": "drug"
        },
        {
          "idx": 6067,
          "name": "CD19",
          "type": "gene/protein",
          "role": "PRIMARY_TARGET"
        },
        {
          "idx": 2250,
          "name": "SYK",
          "type": "gene/protein",
          "role": "B_CELL_MARKER"
        },
        {
          "idx": 33653,
          "name": "melanoma",
          "type": "disease"
        }
      ],
      "attention_scores": [
        0.48622123524546623,
        0.9093517065048218,
        0.5235593002289534
      ],
      "avg_attention": 0.6397107473264138,
      "combined_score": 0.3693371721724017,
      "disease_name": "melanoma",
      "clinical_relevance": "HIGH - Through B-cell protein network"
    },
    {
      "hops": 3,
      "path_type": "B_cell_protein_network",
      "mechanism": "CD19 interacts with SYK (B-cell protein), which is associated with this disease",
      "nodes": [
        {
          "idx": 19645,
          "name": "Inebilizumab",
          "type": "drug"
        },
        {
          "idx": 6067,
          "name": "CD19",
          "type": "gene/protein",
          "role": "PRIMARY_TARGET"
        },
        {
          "idx": 2250,
          "name": "SYK",
          "type": "gene/protein",
          "role": "B_CELL_MARKER"
        },
        {
          "idx": 36621,
          "name": "mesothelioma",
          "type": "disease"
        }
      ],
      "attention_scores": [
        0.48622123524546623,
        0.9093517065048218,
        0.5211631953716278
      ],
      "avg_attention": 0.6389120457073053,
      "combined_score": 0.3688760415776072,
      "disease_name": "mesothelioma",
      "clinical_relevance": "HIGH - Through B-cell protein network"
    },
    {
      "hops": 3,
      "path_type": "B_cell_protein_network",
      "mechanism": "CD19 interacts with CD79A (B-cell protein), which is associated with this disease",
      "nodes": [
        {
          "idx": 19645,
          "name": "Inebilizumab",
          "type": "drug"
        },
        {
          "idx": 6067,
          "name": "CD19",
          "type": "gene/protein",
          "role": "PRIMARY_TARGET"
        },
        {
          "idx": 440,
          "name": "CD79A",
          "type": "gene/protein",
          "role": "B_CELL_MARKER"
        },
        {
          "idx": 35970,
          "name": "lymphoma",
          "type": "disease"
        }
      ],
      "attention_scores": [
        0.48622123524546623,
        0.9040263593196869,
        0.5189841408282518
      ],
      "avg_attention": 0.6364105784644684,
      "combined_score": 0.36743181879158626,
      "disease_name": "lymphoma",
      "clinical_relevance": "HIGH - Through B-cell protein network"
    },
    {
      "hops": 3,
      "path_type": "B_cell_protein_network",
      "mechanism": "CD19 interacts with CD79A (B-cell protein), which is associated with this disease",
      "nodes": [
        {
          "idx": 19645,
          "name": "Inebilizumab",
          "type": "drug"
        },
        {
          "idx": 6067,
          "name": "CD19",
          "type": "gene/protein",
          "role": "PRIMARY_TARGET"
        },
        {
          "idx": 440,
          "name": "CD79A",
          "type": "gene/protein",
          "role": "B_CELL_MARKER"
        },
        {
          "idx": 84157,
          "name": "diffuse large B-cell lymphoma of the central nervous system",
          "type": "disease"
        }
      ],
      "attention_scores": [
        0.48622123524546623,
        0.9040263593196869,
        0.5182838086038828
      ],
      "avg_attention": 0.6361771343896786,
      "combined_score": 0.3672970397921657,
      "disease_name": "diffuse large B-cell lymphoma of the central nervous system",
      "clinical_relevance": "HIGH - Through B-cell protein network"
    },
    {
      "hops": 3,
      "path_type": "B_cell_disease",
      "mechanism": "CD19 protein protein with CD79A, implicated in diffuse large B-cell lymphoma of the central nervous system",
      "nodes": [
        {
          "idx": 19645,
          "name": "Inebilizumab",
          "type": "drug"
        },
        {
          "idx": 6067,
          "name": "CD19",
          "type": "gene/protein",
          "role": "PRIMARY_TARGET"
        },
        {
          "idx": 440,
          "name": "CD79A",
          "type": "gene/protein",
          "role": "B_CELL_MARKER"
        },
        {
          "idx": 84157,
          "name": "diffuse large B-cell lymphoma of the central nervous system",
          "type": "disease"
        }
      ],
      "attention_scores": [
        0.48622123524546623,
        0.9040263593196869,
        0.5182838086038828
      ],
      "avg_attention": 0.6361771343896786,
      "combined_score": 0.3672970397921657,
      "disease_name": "diffuse large B-cell lymphoma of the central nervous system",
      "clinical_relevance": "MEDIUM-HIGH - B-cell related disease"
    },
    {
      "hops": 3,
      "path_type": "B_cell_protein_network",
      "mechanism": "CD19 interacts with CD79A (B-cell protein), which is associated with this disease",
      "nodes": [
        {
          "idx": 19645,
          "name": "Inebilizumab",
          "type": "drug"
        },
        {
          "idx": 6067,
          "name": "CD19",
          "type": "gene/protein",
          "role": "PRIMARY_TARGET"
        },
        {
          "idx": 440,
          "name": "CD79A",
          "type": "gene/protein",
          "role": "B_CELL_MARKER"
        },
        {
          "idx": 84161,
          "name": "intravascular large B-cell lymphoma",
          "type": "disease"
        }
      ],
      "attention_scores": [
        0.48622123524546623,
        0.9040263593196869,
        0.5165599845349789
      ],
      "avg_attention": 0.6356025263667107,
      "combined_score": 0.36696528969542663,
      "disease_name": "intravascular large B-cell lymphoma",
      "clinical_relevance": "HIGH - Through B-cell protein network"
    },
    {
      "hops": 3,
      "path_type": "B_cell_disease",
      "mechanism": "CD19 protein protein with CD79A, implicated in intravascular large B-cell lymphoma",
      "nodes": [
        {
          "idx": 19645,
          "name": "Inebilizumab",
          "type": "drug"
        },
        {
          "idx": 6067,
          "name": "CD19",
          "type": "gene/protein",
          "role": "PRIMARY_TARGET"
        },
        {
          "idx": 440,
          "name": "CD79A",
          "type": "gene/protein",
          "role": "B_CELL_MARKER"
        },
        {
          "idx": 84161,
          "name": "intravascular large B-cell lymphoma",
          "type": "disease"
        }
      ],
      "attention_scores": [
        0.48622123524546623,
        0.9040263593196869,
        0.5165599845349789
      ],
      "avg_attention": 0.6356025263667107,
      "combined_score": 0.36696528969542663,
      "disease_name": "intravascular large B-cell lymphoma",
      "clinical_relevance": "MEDIUM-HIGH - B-cell related disease"
    },
    {
      "hops": 3,
      "path_type": "B_cell_protein_network",
      "mechanism": "CD19 interacts with SYK (B-cell protein), which is associated with this disease",
      "nodes": [
        {
          "idx": 19645,
          "name": "Inebilizumab",
          "type": "drug"
        },
        {
          "idx": 6067,
          "name": "CD19",
          "type": "gene/protein",
          "role": "PRIMARY_TARGET"
        },
        {
          "idx": 2250,
          "name": "SYK",
          "type": "gene/protein",
          "role": "B_CELL_MARKER"
        },
        {
          "idx": 30725,
          "name": "malignant mesothelioma (disease)",
          "type": "disease"
        }
      ],
      "attention_scores": [
        0.48622123524546623,
        0.9093517065048218,
        0.5104788243770599
      ],
      "avg_attention": 0.635350588709116,
      "combined_score": 0.36681983342099533,
      "disease_name": "malignant mesothelioma (disease)",
      "clinical_relevance": "HIGH - Through B-cell protein network"
    },
    {
      "hops": 3,
      "path_type": "B_cell_protein_network",
      "mechanism": "CD19 interacts with CD79A (B-cell protein), which is associated with this disease",
      "nodes": [
        {
          "idx": 19645,
          "name": "Inebilizumab",
          "type": "drug"
        },
        {
          "idx": 6067,
          "name": "CD19",
          "type": "gene/protein",
          "role": "PRIMARY_TARGET"
        },
        {
          "idx": 440,
          "name": "CD79A",
          "type": "gene/protein",
          "role": "B_CELL_MARKER"
        },
        {
          "idx": 84160,
          "name": "primary mediastinal large B-cell lymphoma",
          "type": "disease"
        }
      ],
      "attention_scores": [
        0.48622123524546623,
        0.9040263593196869,
        0.5150868613272905
      ],
      "avg_attention": 0.6351114852974812,
      "combined_score": 0.36668178700192383,
      "disease_name": "primary mediastinal large B-cell lymphoma",
      "clinical_relevance": "HIGH - Through B-cell protein network"
    },
    {
      "hops": 3,
      "path_type": "B_cell_disease",
      "mechanism": "CD19 protein protein with CD79A, implicated in primary mediastinal large B-cell lymphoma",
      "nodes": [
        {
          "idx": 19645,
          "name": "Inebilizumab",
          "type": "drug"
        },
        {
          "idx": 6067,
          "name": "CD19",
          "type": "gene/protein",
          "role": "PRIMARY_TARGET"
        },
        {
          "idx": 440,
          "name": "CD79A",
          "type": "gene/protein",
          "role": "B_CELL_MARKER"
        },
        {
          "idx": 84160,
          "name": "primary mediastinal large B-cell lymphoma",
          "type": "disease"
        }
      ],
      "attention_scores": [
        0.48622123524546623,
        0.9040263593196869,
        0.5150868613272905
      ],
      "avg_attention": 0.6351114852974812,
      "combined_score": 0.36668178700192383,
      "disease_name": "primary mediastinal large B-cell lymphoma",
      "clinical_relevance": "MEDIUM-HIGH - B-cell related disease"
    },
    {
      "hops": 3,
      "path_type": "B_cell_protein_network",
      "mechanism": "CD19 interacts with CD79A (B-cell protein), which is associated with this disease",
      "nodes": [
        {
          "idx": 19645,
          "name": "Inebilizumab",
          "type": "drug"
        },
        {
          "idx": 6067,
          "name": "CD19",
          "type": "gene/protein",
          "role": "PRIMARY_TARGET"
        },
        {
          "idx": 440,
          "name": "CD79A",
          "type": "gene/protein",
          "role": "B_CELL_MARKER"
        },
        {
          "idx": 30447,
          "name": "lymphoma, non-Hodgkin, familial",
          "type": "disease"
        }
      ],
      "attention_scores": [
        0.48622123524546623,
        0.9040263593196869,
        0.5128718856722116
      ],
      "avg_attention": 0.6343731600791216,
      "combined_score": 0.36625551473835444,
      "disease_name": "lymphoma, non-Hodgkin, familial",
      "clinical_relevance": "HIGH - Through B-cell protein network"
    },
    {
      "hops": 3,
      "path_type": "B_cell_protein_network",
      "mechanism": "CD19 interacts with CD79A (B-cell protein), which is associated with this disease",
      "nodes": [
        {
          "idx": 19645,
          "name": "Inebilizumab",
          "type": "drug"
        },
        {
          "idx": 6067,
          "name": "CD19",
          "type": "gene/protein",
          "role": "PRIMARY_TARGET"
        },
        {
          "idx": 440,
          "name": "CD79A",
          "type": "gene/protein",
          "role": "B_CELL_MARKER"
        },
        {
          "idx": 84154,
          "name": "primary cutaneous diffuse large B-cell lymphoma, Leg type",
          "type": "disease"
        }
      ],
      "attention_scores": [
        0.48622123524546623,
        0.9040263593196869,
        0.5118004577234387
      ],
      "avg_attention": 0.6340160174295306,
      "combined_score": 0.366049318333474,
      "disease_name": "primary cutaneous diffuse large B-cell lymphoma, Leg type",
      "clinical_relevance": "HIGH - Through B-cell protein network"
    },
    {
      "hops": 3,
      "path_type": "B_cell_disease",
      "mechanism": "CD19 protein protein with CD79A, implicated in primary cutaneous diffuse large B-cell lymphoma, Leg type",
      "nodes": [
        {
          "idx": 19645,
          "name": "Inebilizumab",
          "type": "drug"
        },
        {
          "idx": 6067,
          "name": "CD19",
          "type": "gene/protein",
          "role": "PRIMARY_TARGET"
        },
        {
          "idx": 440,
          "name": "CD79A",
          "type": "gene/protein",
          "role": "B_CELL_MARKER"
        },
        {
          "idx": 84154,
          "name": "primary cutaneous diffuse large B-cell lymphoma, Leg type",
          "type": "disease"
        }
      ],
      "attention_scores": [
        0.48622123524546623,
        0.9040263593196869,
        0.5118004577234387
      ],
      "avg_attention": 0.6340160174295306,
      "combined_score": 0.366049318333474,
      "disease_name": "primary cutaneous diffuse large B-cell lymphoma, Leg type",
      "clinical_relevance": "MEDIUM-HIGH - B-cell related disease"
    },
    {
      "hops": 3,
      "path_type": "B_cell_protein_network",
      "mechanism": "CD19 interacts with BTK (B-cell protein), which is associated with this disease",
      "nodes": [
        {
          "idx": 19645,
          "name": "Inebilizumab",
          "type": "drug"
        },
        {
          "idx": 6067,
          "name": "CD19",
          "type": "gene/protein",
          "role": "PRIMARY_TARGET"
        },
        {
          "idx": 337,
          "name": "BTK",
          "type": "gene/protein",
          "role": "B_CELL_MARKER"
        },
        {
          "idx": 35737,
          "name": "breast adenocarcinoma",
          "type": "disease"
        }
      ],
      "attention_scores": [
        0.48622123524546623,
        0.8958995044231415,
        0.5199172832071781
      ],
      "avg_attention": 0.6340126742919286,
      "combined_score": 0.36604738817207955,
      "disease_name": "breast adenocarcinoma",
      "clinical_relevance": "HIGH - Through B-cell protein network"
    },
    {
      "hops": 3,
      "path_type": "B_cell_protein_network",
      "mechanism": "CD19 interacts with BTK (B-cell protein), which is associated with this disease",
      "nodes": [
        {
          "idx": 19645,
          "name": "Inebilizumab",
          "type": "drug"
        },
        {
          "idx": 6067,
          "name": "CD19",
          "type": "gene/protein",
          "role": "PRIMARY_TARGET"
        },
        {
          "idx": 337,
          "name": "BTK",
          "type": "gene/protein",
          "role": "B_CELL_MARKER"
        },
        {
          "idx": 83766,
          "name": "short stature due to isolated growth hormone deficiency with X-linked hypogammaglobulinemia",
          "type": "disease"
        }
      ],
      "attention_scores": [
        0.48622123524546623,
        0.8958995044231415,
        0.5192446783185005
      ],
      "avg_attention": 0.6337884726623694,
      "combined_score": 0.36591794530090077,
      "disease_name": "short stature due to isolated growth hormone deficiency with X-linked hypogammaglobulinemia",
      "clinical_relevance": "HIGH - Through B-cell protein network"
    },
    {
      "hops": 3,
      "path_type": "B_cell_protein_network",
      "mechanism": "CD19 interacts with CD79A (B-cell protein), which is associated with this disease",
      "nodes": [
        {
          "idx": 19645,
          "name": "Inebilizumab",
          "type": "drug"
        },
        {
          "idx": 6067,
          "name": "CD19",
          "type": "gene/protein",
          "role": "PRIMARY_TARGET"
        },
        {
          "idx": 440,
          "name": "CD79A",
          "type": "gene/protein",
          "role": "B_CELL_MARKER"
        },
        {
          "idx": 36458,
          "name": "Langerhans cell histiocytosis",
          "type": "disease"
        }
      ],
      "attention_scores": [
        0.48622123524546623,
        0.9040263593196869,
        0.5108242435380816
      ],
      "avg_attention": 0.6336906127010783,
      "combined_score": 0.36586144582590646,
      "disease_name": "Langerhans cell histiocytosis",
      "clinical_relevance": "HIGH - Through B-cell protein network"
    },
    {
      "hops": 3,
      "path_type": "B_cell_protein_network",
      "mechanism": "CD19 interacts with CD79A (B-cell protein), which is associated with this disease",
      "nodes": [
        {
          "idx": 19645,
          "name": "Inebilizumab",
          "type": "drug"
        },
        {
          "idx": 6067,
          "name": "CD19",
          "type": "gene/protein",
          "role": "PRIMARY_TARGET"
        },
        {
          "idx": 440,
          "name": "CD79A",
          "type": "gene/protein",
          "role": "B_CELL_MARKER"
        },
        {
          "idx": 35650,
          "name": "non-Hodgkin lymphoma",
          "type": "disease"
        }
      ],
      "attention_scores": [
        0.48622123524546623,
        0.9040263593196869,
        0.5103628877550364
      ],
      "avg_attention": 0.6335368274400631,
      "combined_score": 0.36577265786406193,
      "disease_name": "non-Hodgkin lymphoma",
      "clinical_relevance": "HIGH - Through B-cell protein network"
    },
    {
      "hops": 3,
      "path_type": "B_cell_protein_network",
      "mechanism": "CD19 interacts with CD79A (B-cell protein), which is associated with this disease",
      "nodes": [
        {
          "idx": 19645,
          "name": "Inebilizumab",
          "type": "drug"
        },
        {
          "idx": 6067,
          "name": "CD19",
          "type": "gene/protein",
          "role": "PRIMARY_TARGET"
        },
        {
          "idx": 440,
          "name": "CD79A",
          "type": "gene/protein",
          "role": "B_CELL_MARKER"
        },
        {
          "idx": 84158,
          "name": "T-cell/histiocyte rich large B cell lymphoma",
          "type": "disease"
        }
      ],
      "attention_scores": [
        0.48622123524546623,
        0.9040263593196869,
        0.5102125545963645
      ],
      "avg_attention": 0.6334867163871726,
      "combined_score": 0.3657437262341862,
      "disease_name": "T-cell/histiocyte rich large B cell lymphoma",
      "clinical_relevance": "HIGH - Through B-cell protein network"
    },
    {
      "hops": 3,
      "path_type": "B_cell_disease",
      "mechanism": "CD19 protein protein with CD79A, implicated in T-cell/histiocyte rich large B cell lymphoma",
      "nodes": [
        {
          "idx": 19645,
          "name": "Inebilizumab",
          "type": "drug"
        },
        {
          "idx": 6067,
          "name": "CD19",
          "type": "gene/protein",
          "role": "PRIMARY_TARGET"
        },
        {
          "idx": 440,
          "name": "CD79A",
          "type": "gene/protein",
          "role": "B_CELL_MARKER"
        },
        {
          "idx": 84158,
          "name": "T-cell/histiocyte rich large B cell lymphoma",
          "type": "disease"
        }
      ],
      "attention_scores": [
        0.48622123524546623,
        0.9040263593196869,
        0.5102125545963645
      ],
      "avg_attention": 0.6334867163871726,
      "combined_score": 0.3657437262341862,
      "disease_name": "T-cell/histiocyte rich large B cell lymphoma",
      "clinical_relevance": "MEDIUM-HIGH - B-cell related disease"
    },
    {
      "hops": 3,
      "path_type": "B_cell_protein_network",
      "mechanism": "CD19 interacts with BTK (B-cell protein), which is associated with this disease",
      "nodes": [
        {
          "idx": 19645,
          "name": "Inebilizumab",
          "type": "drug"
        },
        {
          "idx": 6067,
          "name": "CD19",
          "type": "gene/protein",
          "role": "PRIMARY_TARGET"
        },
        {
          "idx": 337,
          "name": "BTK",
          "type": "gene/protein",
          "role": "B_CELL_MARKER"
        },
        {
          "idx": 84244,
          "name": "undifferentiated carcinoma of the corpus uteri",
          "type": "disease"
        }
      ],
      "attention_scores": [
        0.48622123524546623,
        0.8958995044231415,
        0.5148844700306654
      ],
      "avg_attention": 0.6323350698997577,
      "combined_score": 0.36507882282466597,
      "disease_name": "undifferentiated carcinoma of the corpus uteri",
      "clinical_relevance": "HIGH - Through B-cell protein network"
    },
    {
      "hops": 3,
      "path_type": "B_cell_protein_network",
      "mechanism": "CD19 interacts with BTK (B-cell protein), which is associated with this disease",
      "nodes": [
        {
          "idx": 19645,
          "name": "Inebilizumab",
          "type": "drug"
        },
        {
          "idx": 6067,
          "name": "CD19",
          "type": "gene/protein",
          "role": "PRIMARY_TARGET"
        },
        {
          "idx": 337,
          "name": "BTK",
          "type": "gene/protein",
          "role": "B_CELL_MARKER"
        },
        {
          "idx": 32617,
          "name": "hereditary breast ovarian cancer syndrome",
          "type": "disease"
        }
      ],
      "attention_scores": [
        0.48622123524546623,
        0.8958995044231415,
        0.5145896878093481
      ],
      "avg_attention": 0.6322368091593186,
      "combined_score": 0.3650220919597226,
      "disease_name": "hereditary breast ovarian cancer syndrome",
      "clinical_relevance": "HIGH - Through B-cell protein network"
    },
    {
      "hops": 3,
      "path_type": "B_cell_protein_network",
      "mechanism": "CD19 interacts with CD79A (B-cell protein), which is associated with this disease",
      "nodes": [
        {
          "idx": 19645,
          "name": "Inebilizumab",
          "type": "drug"
        },
        {
          "idx": 6067,
          "name": "CD19",
          "type": "gene/protein",
          "role": "PRIMARY_TARGET"
        },
        {
          "idx": 440,
          "name": "CD79A",
          "type": "gene/protein",
          "role": "B_CELL_MARKER"
        },
        {
          "idx": 32531,
          "name": "mantle cell lymphoma",
          "type": "disease"
        }
      ],
      "attention_scores": [
        0.48622123524546623,
        0.9040263593196869,
        0.5063098734244704
      ],
      "avg_attention": 0.6321858226632079,
      "combined_score": 0.3649926548924681,
      "disease_name": "mantle cell lymphoma",
      "clinical_relevance": "HIGH - Through B-cell protein network"
    },
    {
      "hops": 3,
      "path_type": "B_cell_protein_network",
      "mechanism": "CD19 interacts with CD79A (B-cell protein), which is associated with this disease",
      "nodes": [
        {
          "idx": 19645,
          "name": "Inebilizumab",
          "type": "drug"
        },
        {
          "idx": 6067,
          "name": "CD19",
          "type": "gene/protein",
          "role": "PRIMARY_TARGET"
        },
        {
          "idx": 440,
          "name": "CD79A",
          "type": "gene/protein",
          "role": "B_CELL_MARKER"
        },
        {
          "idx": 35884,
          "name": "diffuse large B-cell lymphoma",
          "type": "disease"
        }
      ],
      "attention_scores": [
        0.48622123524546623,
        0.9040263593196869,
        0.5060533420182765
      ],
      "avg_attention": 0.6321003121944765,
      "combined_score": 0.3649432854003275,
      "disease_name": "diffuse large B-cell lymphoma",
      "clinical_relevance": "HIGH - Through B-cell protein network"
    },
    {
      "hops": 3,
      "path_type": "B_cell_protein_network",
      "mechanism": "CD19 interacts with BTK (B-cell protein), which is associated with this disease",
      "nodes": [
        {
          "idx": 19645,
          "name": "Inebilizumab",
          "type": "drug"
        },
        {
          "idx": 6067,
          "name": "CD19",
          "type": "gene/protein",
          "role": "PRIMARY_TARGET"
        },
        {
          "idx": 337,
          "name": "BTK",
          "type": "gene/protein",
          "role": "B_CELL_MARKER"
        },
        {
          "idx": 37338,
          "name": "lung large cell carcinoma",
          "type": "disease"
        }
      ],
      "attention_scores": [
        0.48622123524546623,
        0.8958995044231415,
        0.5140565754845738
      ],
      "avg_attention": 0.6320591050510606,
      "combined_score": 0.3649194944449838,
      "disease_name": "lung large cell carcinoma",
      "clinical_relevance": "HIGH - Through B-cell protein network"
    },
    {
      "hops": 3,
      "path_type": "B_cell_protein_network",
      "mechanism": "CD19 interacts with BTK (B-cell protein), which is associated with this disease",
      "nodes": [
        {
          "idx": 19645,
          "name": "Inebilizumab",
          "type": "drug"
        },
        {
          "idx": 6067,
          "name": "CD19",
          "type": "gene/protein",
          "role": "PRIMARY_TARGET"
        },
        {
          "idx": 337,
          "name": "BTK",
          "type": "gene/protein",
          "role": "B_CELL_MARKER"
        },
        {
          "idx": 30828,
          "name": "Bruton-type agammaglobulinemia",
          "type": "disease"
        }
      ],
      "attention_scores": [
        0.48622123524546623,
        0.8958995044231415,
        0.5127518251538277
      ],
      "avg_attention": 0.6316241882741451,
      "combined_score": 0.3646683951267566,
      "disease_name": "Bruton-type agammaglobulinemia",
      "clinical_relevance": "HIGH - Through B-cell protein network"
    },
    {
      "hops": 3,
      "path_type": "B_cell_disease",
      "mechanism": "CD19 protein protein with BTK, implicated in Bruton-type agammaglobulinemia",
      "nodes": [
        {
          "idx": 19645,
          "name": "Inebilizumab",
          "type": "drug"
        },
        {
          "idx": 6067,
          "name": "CD19",
          "type": "gene/protein",
          "role": "PRIMARY_TARGET"
        },
        {
          "idx": 337,
          "name": "BTK",
          "type": "gene/protein",
          "role": "B_CELL_MARKER"
        },
        {
          "idx": 30828,
          "name": "Bruton-type agammaglobulinemia",
          "type": "disease"
        }
      ],
      "attention_scores": [
        0.48622123524546623,
        0.8958995044231415,
        0.5127518251538277
      ],
      "avg_attention": 0.6316241882741451,
      "combined_score": 0.3646683951267566,
      "disease_name": "Bruton-type agammaglobulinemia",
      "clinical_relevance": "MEDIUM-HIGH - B-cell related disease"
    },
    {
      "hops": 3,
      "path_type": "B_cell_protein_network",
      "mechanism": "CD19 interacts with CD79A (B-cell protein), which is associated with this disease",
      "nodes": [
        {
          "idx": 19645,
          "name": "Inebilizumab",
          "type": "drug"
        },
        {
          "idx": 6067,
          "name": "CD19",
          "type": "gene/protein",
          "role": "PRIMARY_TARGET"
        },
        {
          "idx": 440,
          "name": "CD79A",
          "type": "gene/protein",
          "role": "B_CELL_MARKER"
        },
        {
          "idx": 84155,
          "name": "Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly",
          "type": "disease"
        }
      ],
      "attention_scores": [
        0.48622123524546623,
        0.9040263593196869,
        0.5042648506350815
      ],
      "avg_attention": 0.6315041484000782,
      "combined_score": 0.36459909007315056,
      "disease_name": "Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly",
      "clinical_relevance": "HIGH - Through B-cell protein network"
    },
    {
      "hops": 3,
      "path_type": "B_cell_disease",
      "mechanism": "CD19 protein protein with CD79A, implicated in Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly",
      "nodes": [
        {
          "idx": 19645,
          "name": "Inebilizumab",
          "type": "drug"
        },
        {
          "idx": 6067,
          "name": "CD19",
          "type": "gene/protein",
          "role": "PRIMARY_TARGET"
        },
        {
          "idx": 440,
          "name": "CD79A",
          "type": "gene/protein",
          "role": "B_CELL_MARKER"
        },
        {
          "idx": 84155,
          "name": "Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly",
          "type": "disease"
        }
      ],
      "attention_scores": [
        0.48622123524546623,
        0.9040263593196869,
        0.5042648506350815
      ],
      "avg_attention": 0.6315041484000782,
      "combined_score": 0.36459909007315056,
      "disease_name": "Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly",
      "clinical_relevance": "MEDIUM-HIGH - B-cell related disease"
    },
    {
      "hops": 3,
      "path_type": "B_cell_protein_network",
      "mechanism": "CD19 interacts with CD79A (B-cell protein), which is associated with this disease",
      "nodes": [
        {
          "idx": 19645,
          "name": "Inebilizumab",
          "type": "drug"
        },
        {
          "idx": 6067,
          "name": "CD19",
          "type": "gene/protein",
          "role": "PRIMARY_TARGET"
        },
        {
          "idx": 440,
          "name": "CD79A",
          "type": "gene/protein",
          "role": "B_CELL_MARKER"
        },
        {
          "idx": 84156,
          "name": "plasmablastic lymphoma",
          "type": "disease"
        }
      ],
      "attention_scores": [
        0.48622123524546623,
        0.9040263593196869,
        0.5038788339588791
      ],
      "avg_attention": 0.6313754761746774,
      "combined_score": 0.3645248011291782,
      "disease_name": "plasmablastic lymphoma",
      "clinical_relevance": "HIGH - Through B-cell protein network"
    },
    {
      "hops": 3,
      "path_type": "B_cell_disease",
      "mechanism": "CD19 protein protein with CD79A, implicated in plasmablastic lymphoma",
      "nodes": [
        {
          "idx": 19645,
          "name": "Inebilizumab",
          "type": "drug"
        },
        {
          "idx": 6067,
          "name": "CD19",
          "type": "gene/protein",
          "role": "PRIMARY_TARGET"
        },
        {
          "idx": 440,
          "name": "CD79A",
          "type": "gene/protein",
          "role": "B_CELL_MARKER"
        },
        {
          "idx": 84156,
          "name": "plasmablastic lymphoma",
          "type": "disease"
        }
      ],
      "attention_scores": [
        0.48622123524546623,
        0.9040263593196869,
        0.5038788339588791
      ],
      "avg_attention": 0.6313754761746774,
      "combined_score": 0.3645248011291782,
      "disease_name": "plasmablastic lymphoma",
      "clinical_relevance": "MEDIUM-HIGH - B-cell related disease"
    },
    {
      "hops": 3,
      "path_type": "B_cell_protein_network",
      "mechanism": "CD19 interacts with BTK (B-cell protein), which is associated with this disease",
      "nodes": [
        {
          "idx": 19645,
          "name": "Inebilizumab",
          "type": "drug"
        },
        {
          "idx": 6067,
          "name": "CD19",
          "type": "gene/protein",
          "role": "PRIMARY_TARGET"
        },
        {
          "idx": 337,
          "name": "BTK",
          "type": "gene/protein",
          "role": "B_CELL_MARKER"
        },
        {
          "idx": 38989,
          "name": "congenital agammaglobulinemia",
          "type": "disease"
        }
      ],
      "attention_scores": [
        0.48622123524546623,
        0.8958995044231415,
        0.5116697289049625
      ],
      "avg_attention": 0.6312634895245234,
      "combined_score": 0.3644601456065661,
      "disease_name": "congenital agammaglobulinemia",
      "clinical_relevance": "HIGH - Through B-cell protein network"
    },
    {
      "hops": 3,
      "path_type": "B_cell_disease",
      "mechanism": "CD19 protein protein with BTK, implicated in congenital agammaglobulinemia",
      "nodes": [
        {
          "idx": 19645,
          "name": "Inebilizumab",
          "type": "drug"
        },
        {
          "idx": 6067,
          "name": "CD19",
          "type": "gene/protein",
          "role": "PRIMARY_TARGET"
        },
        {
          "idx": 337,
          "name": "BTK",
          "type": "gene/protein",
          "role": "B_CELL_MARKER"
        },
        {
          "idx": 38989,
          "name": "congenital agammaglobulinemia",
          "type": "disease"
        }
      ],
      "attention_scores": [
        0.48622123524546623,
        0.8958995044231415,
        0.5116697289049625
      ],
      "avg_attention": 0.6312634895245234,
      "combined_score": 0.3644601456065661,
      "disease_name": "congenital agammaglobulinemia",
      "clinical_relevance": "MEDIUM-HIGH - B-cell related disease"
    },
    {
      "hops": 3,
      "path_type": "B_cell_protein_network",
      "mechanism": "CD19 interacts with CD79A (B-cell protein), which is associated with this disease",
      "nodes": [
        {
          "idx": 19645,
          "name": "Inebilizumab",
          "type": "drug"
        },
        {
          "idx": 6067,
          "name": "CD19",
          "type": "gene/protein",
          "role": "PRIMARY_TARGET"
        },
        {
          "idx": 440,
          "name": "CD79A",
          "type": "gene/protein",
          "role": "B_CELL_MARKER"
        },
        {
          "idx": 84159,
          "name": "ALK-positive large B-cell lymphoma",
          "type": "disease"
        }
      ],
      "attention_scores": [
        0.48622123524546623,
        0.9040263593196869,
        0.502692878479138
      ],
      "avg_attention": 0.6309801576814303,
      "combined_score": 0.3642965638906863,
      "disease_name": "ALK-positive large B-cell lymphoma",
      "clinical_relevance": "HIGH - Through B-cell protein network"
    },
    {
      "hops": 3,
      "path_type": "B_cell_disease",
      "mechanism": "CD19 protein protein with CD79A, implicated in ALK-positive large B-cell lymphoma",
      "nodes": [
        {
          "idx": 19645,
          "name": "Inebilizumab",
          "type": "drug"
        },
        {
          "idx": 6067,
          "name": "CD19",
          "type": "gene/protein",
          "role": "PRIMARY_TARGET"
        },
        {
          "idx": 440,
          "name": "CD79A",
          "type": "gene/protein",
          "role": "B_CELL_MARKER"
        },
        {
          "idx": 84159,
          "name": "ALK-positive large B-cell lymphoma",
          "type": "disease"
        }
      ],
      "attention_scores": [
        0.48622123524546623,
        0.9040263593196869,
        0.502692878479138
      ],
      "avg_attention": 0.6309801576814303,
      "combined_score": 0.3642965638906863,
      "disease_name": "ALK-positive large B-cell lymphoma",
      "clinical_relevance": "MEDIUM-HIGH - B-cell related disease"
    },
    {
      "hops": 3,
      "path_type": "B_cell_protein_network",
      "mechanism": "CD19 interacts with SYK (B-cell protein), which is associated with this disease",
      "nodes": [
        {
          "idx": 19645,
          "name": "Inebilizumab",
          "type": "drug"
        },
        {
          "idx": 6067,
          "name": "CD19",
          "type": "gene/protein",
          "role": "PRIMARY_TARGET"
        },
        {
          "idx": 2250,
          "name": "SYK",
          "type": "gene/protein",
          "role": "B_CELL_MARKER"
        },
        {
          "idx": 36386,
          "name": "benign mesothelioma",
          "type": "disease"
        }
      ],
      "attention_scores": [
        0.48622123524546623,
        0.9093517065048218,
        0.4966164925135672
      ],
      "avg_attention": 0.630729811421285,
      "combined_score": 0.36415202641000083,
      "disease_name": "benign mesothelioma",
      "clinical_relevance": "HIGH - Through B-cell protein network"
    },
    {
      "hops": 3,
      "path_type": "B_cell_protein_network",
      "mechanism": "CD19 interacts with BTK (B-cell protein), which is associated with this disease",
      "nodes": [
        {
          "idx": 19645,
          "name": "Inebilizumab",
          "type": "drug"
        },
        {
          "idx": 6067,
          "name": "CD19",
          "type": "gene/protein",
          "role": "PRIMARY_TARGET"
        },
        {
          "idx": 337,
          "name": "BTK",
          "type": "gene/protein",
          "role": "B_CELL_MARKER"
        },
        {
          "idx": 94678,
          "name": "benign breast phyllodes tumor",
          "type": "disease"
        }
      ],
      "attention_scores": [
        0.48622123524546623,
        0.8958995044231415,
        0.5095976619049907
      ],
      "avg_attention": 0.6305728005245328,
      "combined_score": 0.3640613761264952,
      "disease_name": "benign breast phyllodes tumor",
      "clinical_relevance": "HIGH - Through B-cell protein network"
    },
    {
      "hops": 3,
      "path_type": "B_cell_protein_network",
      "mechanism": "CD19 interacts with BTK (B-cell protein), which is associated with this disease",
      "nodes": [
        {
          "idx": 19645,
          "name": "Inebilizumab",
          "type": "drug"
        },
        {
          "idx": 6067,
          "name": "CD19",
          "type": "gene/protein",
          "role": "PRIMARY_TARGET"
        },
        {
          "idx": 337,
          "name": "BTK",
          "type": "gene/protein",
          "role": "B_CELL_MARKER"
        },
        {
          "idx": 35771,
          "name": "breast neoplasm",
          "type": "disease"
        }
      ],
      "attention_scores": [
        0.48622123524546623,
        0.8958995044231415,
        0.5089422715827823
      ],
      "avg_attention": 0.6303543370837966,
      "combined_score": 0.3639352462001781,
      "disease_name": "breast neoplasm",
      "clinical_relevance": "HIGH - Through B-cell protein network"
    },
    {
      "hops": 3,
      "path_type": "B_cell_protein_network",
      "mechanism": "CD19 interacts with BTK (B-cell protein), which is associated with this disease",
      "nodes": [
        {
          "idx": 19645,
          "name": "Inebilizumab",
          "type": "drug"
        },
        {
          "idx": 6067,
          "name": "CD19",
          "type": "gene/protein",
          "role": "PRIMARY_TARGET"
        },
        {
          "idx": 337,
          "name": "BTK",
          "type": "gene/protein",
          "role": "B_CELL_MARKER"
        },
        {
          "idx": 30654,
          "name": "acute lymphoblastic/lymphocytic leukemia",
          "type": "disease"
        }
      ],
      "attention_scores": [
        0.48622123524546623,
        0.8958995044231415,
        0.5087962886318564
      ],
      "avg_attention": 0.6303056761001548,
      "combined_score": 0.36390715176817345,
      "disease_name": "acute lymphoblastic/lymphocytic leukemia",
      "clinical_relevance": "HIGH - Through B-cell protein network"
    },
    {
      "hops": 3,
      "path_type": "B_cell_protein_network",
      "mechanism": "CD19 interacts with CD79A (B-cell protein), which is associated with this disease",
      "nodes": [
        {
          "idx": 19645,
          "name": "Inebilizumab",
          "type": "drug"
        },
        {
          "idx": 6067,
          "name": "CD19",
          "type": "gene/protein",
          "role": "PRIMARY_TARGET"
        },
        {
          "idx": 440,
          "name": "CD79A",
          "type": "gene/protein",
          "role": "B_CELL_MARKER"
        },
        {
          "idx": 36425,
          "name": "primary central nervous system lymphoma",
          "type": "disease"
        }
      ],
      "attention_scores": [
        0.48622123524546623,
        0.9040263593196869,
        0.5002249873214168
      ],
      "avg_attention": 0.6301575272955233,
      "combined_score": 0.3638216180159394,
      "disease_name": "primary central nervous system lymphoma",
      "clinical_relevance": "HIGH - Through B-cell protein network"
    },
    {
      "hops": 3,
      "path_type": "B_cell_protein_network",
      "mechanism": "CD19 interacts with CD79A (B-cell protein), which is associated with this disease",
      "nodes": [
        {
          "idx": 19645,
          "name": "Inebilizumab",
          "type": "drug"
        },
        {
          "idx": 6067,
          "name": "CD19",
          "type": "gene/protein",
          "role": "PRIMARY_TARGET"
        },
        {
          "idx": 440,
          "name": "CD79A",
          "type": "gene/protein",
          "role": "B_CELL_MARKER"
        },
        {
          "idx": 37267,
          "name": "syndromic agammaglobulinemia",
          "type": "disease"
        }
      ],
      "attention_scores": [
        0.48622123524546623,
        0.9040263593196869,
        0.5
      ],
      "avg_attention": 0.6300825315217177,
      "combined_score": 0.3637783191857446,
      "disease_name": "syndromic agammaglobulinemia",
      "clinical_relevance": "HIGH - Through B-cell protein network"
    },
    {
      "hops": 3,
      "path_type": "B_cell_protein_network",
      "mechanism": "CD19 interacts with BTK (B-cell protein), which is associated with this disease",
      "nodes": [
        {
          "idx": 19645,
          "name": "Inebilizumab",
          "type": "drug"
        },
        {
          "idx": 6067,
          "name": "CD19",
          "type": "gene/protein",
          "role": "PRIMARY_TARGET"
        },
        {
          "idx": 337,
          "name": "BTK",
          "type": "gene/protein",
          "role": "B_CELL_MARKER"
        },
        {
          "idx": 28347,
          "name": "hereditary breast carcinoma",
          "type": "disease"
        }
      ],
      "attention_scores": [
        0.48622123524546623,
        0.8958995044231415,
        0.5068918326869607
      ],
      "avg_attention": 0.6296708574518561,
      "combined_score": 0.3635406390506916,
      "disease_name": "hereditary breast carcinoma",
      "clinical_relevance": "HIGH - Through B-cell protein network"
    },
    {
      "hops": 3,
      "path_type": "B_cell_protein_network",
      "mechanism": "CD19 interacts with CD79A (B-cell protein), which is associated with this disease",
      "nodes": [
        {
          "idx": 19645,
          "name": "Inebilizumab",
          "type": "drug"
        },
        {
          "idx": 6067,
          "name": "CD19",
          "type": "gene/protein",
          "role": "PRIMARY_TARGET"
        },
        {
          "idx": 440,
          "name": "CD79A",
          "type": "gene/protein",
          "role": "B_CELL_MARKER"
        },
        {
          "idx": 35651,
          "name": "B-cell neoplasm",
          "type": "disease"
        }
      ],
      "attention_scores": [
        0.48622123524546623,
        0.9040263593196869,
        0.4982375878607854
      ],
      "avg_attention": 0.6294950608086461,
      "combined_score": 0.3634391428114117,
      "disease_name": "B-cell neoplasm",
      "clinical_relevance": "HIGH - Through B-cell protein network"
    },
    {
      "hops": 3,
      "path_type": "B_cell_protein_network",
      "mechanism": "CD19 interacts with CD79A (B-cell protein), which is associated with this disease",
      "nodes": [
        {
          "idx": 19645,
          "name": "Inebilizumab",
          "type": "drug"
        },
        {
          "idx": 6067,
          "name": "CD19",
          "type": "gene/protein",
          "role": "PRIMARY_TARGET"
        },
        {
          "idx": 440,
          "name": "CD79A",
          "type": "gene/protein",
          "role": "B_CELL_MARKER"
        },
        {
          "idx": 27170,
          "name": "agammaglobulinemia",
          "type": "disease"
        }
      ],
      "attention_scores": [
        0.48622123524546623,
        0.9040263593196869,
        0.496008959133178
      ],
      "avg_attention": 0.6287521845661104,
      "combined_score": 0.3630102430128091,
      "disease_name": "agammaglobulinemia",
      "clinical_relevance": "HIGH - Through B-cell protein network"
    },
    {
      "hops": 2,
      "path_type": "CD19_direct_target",
      "mechanism": "Inebilizumab targets CD19, which is associated with this disease",
      "nodes": [
        {
          "idx": 19645,
          "name": "Inebilizumab",
          "type": "drug"
        },
        {
          "idx": 6067,
          "name": "CD19",
          "type": "gene/protein",
          "role": "PRIMARY_TARGET"
        },
        {
          "idx": 32587,
          "name": "common variable immunodeficiency",
          "type": "disease"
        }
      ],
      "attention_scores": [
        0.48622123524546623,
        0.5391860827803612
      ],
      "avg_attention": 0.5127036590129137,
      "combined_score": 0.3625362340271866,
      "disease_name": "common variable immunodeficiency",
      "clinical_relevance": "HIGH - Direct target-disease connection"
    },
    {
      "hops": 3,
      "path_type": "B_cell_protein_network",
      "mechanism": "CD19 interacts with BTK (B-cell protein), which is associated with this disease",
      "nodes": [
        {
          "idx": 19645,
          "name": "Inebilizumab",
          "type": "drug"
        },
        {
          "idx": 6067,
          "name": "CD19",
          "type": "gene/protein",
          "role": "PRIMARY_TARGET"
        },
        {
          "idx": 337,
          "name": "BTK",
          "type": "gene/protein",
          "role": "B_CELL_MARKER"
        },
        {
          "idx": 36691,
          "name": "breast cancer",
          "type": "disease"
        }
      ],
      "attention_scores": [
        0.48622123524546623,
        0.8958995044231415,
        0.5005330126732588
      ],
      "avg_attention": 0.6275512507806221,
      "combined_score": 0.3623168835684786,
      "disease_name": "breast cancer",
      "clinical_relevance": "HIGH - Through B-cell protein network"
    },
    {
      "hops": 3,
      "path_type": "B_cell_protein_network",
      "mechanism": "CD19 interacts with BTK (B-cell protein), which is associated with this disease",
      "nodes": [
        {
          "idx": 19645,
          "name": "Inebilizumab",
          "type": "drug"
        },
        {
          "idx": 6067,
          "name": "CD19",
          "type": "gene/protein",
          "role": "PRIMARY_TARGET"
        },
        {
          "idx": 337,
          "name": "BTK",
          "type": "gene/protein",
          "role": "B_CELL_MARKER"
        },
        {
          "idx": 27249,
          "name": "isolated growth hormone deficiency",
          "type": "disease"
        }
      ],
      "attention_scores": [
        0.48622123524546623,
        0.8958995044231415,
        0.5
      ],
      "avg_attention": 0.6273735798895359,
      "combined_score": 0.36221430523168274,
      "disease_name": "isolated growth hormone deficiency",
      "clinical_relevance": "HIGH - Through B-cell protein network"
    },
    {
      "hops": 2,
      "path_type": "CD19_direct_target",
      "mechanism": "Inebilizumab targets CD19, which is associated with this disease",
      "nodes": [
        {
          "idx": 19645,
          "name": "Inebilizumab",
          "type": "drug"
        },
        {
          "idx": 6067,
          "name": "CD19",
          "type": "gene/protein",
          "role": "PRIMARY_TARGET"
        },
        {
          "idx": 27188,
          "name": "immunodeficiency, common variable",
          "type": "disease"
        }
      ],
      "attention_scores": [
        0.48622123524546623,
        0.5368110537528992
      ],
      "avg_attention": 0.5115161444991827,
      "combined_score": 0.36169653446176997,
      "disease_name": "immunodeficiency, common variable",
      "clinical_relevance": "HIGH - Direct target-disease connection"
    },
    {
      "hops": 3,
      "path_type": "B_cell_protein_network",
      "mechanism": "CD19 interacts with BTK (B-cell protein), which is associated with this disease",
      "nodes": [
        {
          "idx": 19645,
          "name": "Inebilizumab",
          "type": "drug"
        },
        {
          "idx": 6067,
          "name": "CD19",
          "type": "gene/protein",
          "role": "PRIMARY_TARGET"
        },
        {
          "idx": 337,
          "name": "BTK",
          "type": "gene/protein",
          "role": "B_CELL_MARKER"
        },
        {
          "idx": 37334,
          "name": "breast carcinoma",
          "type": "disease"
        }
      ],
      "attention_scores": [
        0.48622123524546623,
        0.8958995044231415,
        0.4969235663302243
      ],
      "avg_attention": 0.6263481019996107,
      "combined_score": 0.36162224529588644,
      "disease_name": "breast carcinoma",
      "clinical_relevance": "HIGH - Through B-cell protein network"
    },
    {
      "hops": 3,
      "path_type": "B_cell_protein_network",
      "mechanism": "CD19 interacts with BTK (B-cell protein), which is associated with this disease",
      "nodes": [
        {
          "idx": 19645,
          "name": "Inebilizumab",
          "type": "drug"
        },
        {
          "idx": 6067,
          "name": "CD19",
          "type": "gene/protein",
          "role": "PRIMARY_TARGET"
        },
        {
          "idx": 337,
          "name": "BTK",
          "type": "gene/protein",
          "role": "B_CELL_MARKER"
        },
        {
          "idx": 84243,
          "name": "squamous cell carcinoma of the corpus uteri",
          "type": "disease"
        }
      ],
      "attention_scores": [
        0.48622123524546623,
        0.8958995044231415,
        0.4932358143851161
      ],
      "avg_attention": 0.6251188513512412,
      "combined_score": 0.3609125371031488,
      "disease_name": "squamous cell carcinoma of the corpus uteri",
      "clinical_relevance": "HIGH - Through B-cell protein network"
    },
    {
      "hops": 3,
      "path_type": "B_cell_protein_network",
      "mechanism": "CD19 interacts with BTK (B-cell protein), which is associated with this disease",
      "nodes": [
        {
          "idx": 19645,
          "name": "Inebilizumab",
          "type": "drug"
        },
        {
          "idx": 6067,
          "name": "CD19",
          "type": "gene/protein",
          "role": "PRIMARY_TARGET"
        },
        {
          "idx": 337,
          "name": "BTK",
          "type": "gene/protein",
          "role": "B_CELL_MARKER"
        },
        {
          "idx": 83868,
          "name": "Richter syndrome",
          "type": "disease"
        }
      ],
      "attention_scores": [
        0.48622123524546623,
        0.8958995044231415,
        0.49041944183409214
      ],
      "avg_attention": 0.6241800605008999,
      "combined_score": 0.36037052595299146,
      "disease_name": "Richter syndrome",
      "clinical_relevance": "HIGH - Through B-cell protein network"
    },
    {
      "hops": 2,
      "path_type": "CD19_direct_target",
      "mechanism": "Inebilizumab targets CD19, which is associated with this disease",
      "nodes": [
        {
          "idx": 19645,
          "name": "Inebilizumab",
          "type": "drug"
        },
        {
          "idx": 6067,
          "name": "CD19",
          "type": "gene/protein",
          "role": "PRIMARY_TARGET"
        },
        {
          "idx": 27170,
          "name": "agammaglobulinemia",
          "type": "disease"
        }
      ],
      "attention_scores": [
        0.48622123524546623,
        0.5138264540582895
      ],
      "avg_attention": 0.5000238446518779,
      "combined_score": 0.3535702513083116,
      "disease_name": "agammaglobulinemia",
      "clinical_relevance": "HIGH - Direct target-disease connection"
    },
    {
      "hops": 2,
      "path_type": "CD19_direct_target",
      "mechanism": "Inebilizumab targets CD19, which is associated with this disease",
      "nodes": [
        {
          "idx": 19645,
          "name": "Inebilizumab",
          "type": "drug"
        },
        {
          "idx": 6067,
          "name": "CD19",
          "type": "gene/protein",
          "role": "PRIMARY_TARGET"
        },
        {
          "idx": 37267,
          "name": "syndromic agammaglobulinemia",
          "type": "disease"
        }
      ],
      "attention_scores": [
        0.48622123524546623,
        0.5
      ],
      "avg_attention": 0.4931106176227331,
      "combined_score": 0.34868186159612125,
      "disease_name": "syndromic agammaglobulinemia",
      "clinical_relevance": "HIGH - Direct target-disease connection"
    },
    {
      "hops": 3,
      "path_type": "B_cell_protein_network",
      "mechanism": "CD19 interacts with PAX5 (B-cell protein), which is associated with this disease",
      "nodes": [
        {
          "idx": 19645,
          "name": "Inebilizumab",
          "type": "drug"
        },
        {
          "idx": 6067,
          "name": "CD19",
          "type": "gene/protein",
          "role": "PRIMARY_TARGET"
        },
        {
          "idx": 309,
          "name": "PAX5",
          "type": "gene/protein",
          "role": "B_CELL_MARKER"
        },
        {
          "idx": 33621,
          "name": "acute lymphoblastic leukemia (disease)",
          "type": "disease"
        }
      ],
      "attention_scores": [
        0.48622123524546623,
        0.7917563617229462,
        0.5117503674700856
      ],
      "avg_attention": 0.596575988146166,
      "combined_score": 0.34443330734825595,
      "disease_name": "acute lymphoblastic leukemia (disease)",
      "clinical_relevance": "HIGH - Through B-cell protein network"
    },
    {
      "hops": 3,
      "path_type": "B_cell_protein_network",
      "mechanism": "CD19 interacts with PAX5 (B-cell protein), which is associated with this disease",
      "nodes": [
        {
          "idx": 19645,
          "name": "Inebilizumab",
          "type": "drug"
        },
        {
          "idx": 6067,
          "name": "CD19",
          "type": "gene/protein",
          "role": "PRIMARY_TARGET"
        },
        {
          "idx": 309,
          "name": "PAX5",
          "type": "gene/protein",
          "role": "B_CELL_MARKER"
        },
        {
          "idx": 35866,
          "name": "precursor lymphoblastic lymphoma/leukemia",
          "type": "disease"
        }
      ],
      "attention_scores": [
        0.48622123524546623,
        0.7917563617229462,
        0.5098392004147172
      ],
      "avg_attention": 0.5959389324610432,
      "combined_score": 0.34406550307696154,
      "disease_name": "precursor lymphoblastic lymphoma/leukemia",
      "clinical_relevance": "HIGH - Through B-cell protein network"
    },
    {
      "hops": 3,
      "path_type": "B_cell_protein_network",
      "mechanism": "CD19 interacts with PAX5 (B-cell protein), which is associated with this disease",
      "nodes": [
        {
          "idx": 19645,
          "name": "Inebilizumab",
          "type": "drug"
        },
        {
          "idx": 6067,
          "name": "CD19",
          "type": "gene/protein",
          "role": "PRIMARY_TARGET"
        },
        {
          "idx": 309,
          "name": "PAX5",
          "type": "gene/protein",
          "role": "B_CELL_MARKER"
        },
        {
          "idx": 28830,
          "name": "leukemia, lymphocytic, susceptibility to",
          "type": "disease"
        }
      ],
      "attention_scores": [
        0.48622123524546623,
        0.7917563617229462,
        0.5012555319117382
      ],
      "avg_attention": 0.5930777096267169,
      "combined_score": 0.34241357530335176,
      "disease_name": "leukemia, lymphocytic, susceptibility to",
      "clinical_relevance": "HIGH - Through B-cell protein network"
    },
    {
      "hops": 3,
      "path_type": "B_cell_disease",
      "mechanism": "CD19 protein protein with PAX5, implicated in leukemia, lymphocytic, susceptibility to",
      "nodes": [
        {
          "idx": 19645,
          "name": "Inebilizumab",
          "type": "drug"
        },
        {
          "idx": 6067,
          "name": "CD19",
          "type": "gene/protein",
          "role": "PRIMARY_TARGET"
        },
        {
          "idx": 309,
          "name": "PAX5",
          "type": "gene/protein",
          "role": "B_CELL_MARKER"
        },
        {
          "idx": 28830,
          "name": "leukemia, lymphocytic, susceptibility to",
          "type": "disease"
        }
      ],
      "attention_scores": [
        0.48622123524546623,
        0.7917563617229462,
        0.5012555319117382
      ],
      "avg_attention": 0.5930777096267169,
      "combined_score": 0.34241357530335176,
      "disease_name": "leukemia, lymphocytic, susceptibility to",
      "clinical_relevance": "MEDIUM-HIGH - B-cell related disease"
    },
    {
      "hops": 3,
      "path_type": "B_cell_protein_network",
      "mechanism": "CD19 interacts with PAX5 (B-cell protein), which is associated with this disease",
      "nodes": [
        {
          "idx": 19645,
          "name": "Inebilizumab",
          "type": "drug"
        },
        {
          "idx": 6067,
          "name": "CD19",
          "type": "gene/protein",
          "role": "PRIMARY_TARGET"
        },
        {
          "idx": 309,
          "name": "PAX5",
          "type": "gene/protein",
          "role": "B_CELL_MARKER"
        },
        {
          "idx": 30075,
          "name": "Burkitt lymphoma",
          "type": "disease"
        }
      ],
      "attention_scores": [
        0.48622123524546623,
        0.7917563617229462,
        0.4991455393610522
      ],
      "avg_attention": 0.5923743787764882,
      "combined_score": 0.3420075070476428,
      "disease_name": "Burkitt lymphoma",
      "clinical_relevance": "HIGH - Through B-cell protein network"
    },
    {
      "hops": 3,
      "path_type": "B_cell_protein_network",
      "mechanism": "CD19 interacts with PAX5 (B-cell protein), which is associated with this disease",
      "nodes": [
        {
          "idx": 19645,
          "name": "Inebilizumab",
          "type": "drug"
        },
        {
          "idx": 6067,
          "name": "CD19",
          "type": "gene/protein",
          "role": "PRIMARY_TARGET"
        },
        {
          "idx": 309,
          "name": "PAX5",
          "type": "gene/protein",
          "role": "B_CELL_MARKER"
        },
        {
          "idx": 35852,
          "name": "acute lymphoblastic leukemia",
          "type": "disease"
        }
      ],
      "attention_scores": [
        0.48622123524546623,
        0.7917563617229462,
        0.4770771097391844
      ],
      "avg_attention": 0.585018235569199,
      "combined_score": 0.33776043578671694,
      "disease_name": "acute lymphoblastic leukemia",
      "clinical_relevance": "HIGH - Through B-cell protein network"
    }
  ],
  "paths_by_type": {
    "B_cell_protein_network": [
      {
        "hops": 3,
        "path_type": "B_cell_protein_network",
        "mechanism": "CD19 interacts with CD79A (B-cell protein), which is associated with this disease",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 440,
            "name": "CD79A",
            "type": "gene/protein",
            "role": "B_CELL_MARKER"
          },
          {
            "idx": 83796,
            "name": "lymphosarcoma",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.9040263593196869,
          0.5310772471129894
        ],
        "avg_attention": 0.6404416138927141,
        "combined_score": 0.3697591381811969,
        "disease_name": "lymphosarcoma",
        "clinical_relevance": "HIGH - Through B-cell protein network"
      },
      {
        "hops": 3,
        "path_type": "B_cell_protein_network",
        "mechanism": "CD19 interacts with SYK (B-cell protein), which is associated with this disease",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 2250,
            "name": "SYK",
            "type": "gene/protein",
            "role": "B_CELL_MARKER"
          },
          {
            "idx": 33653,
            "name": "melanoma",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.9093517065048218,
          0.5235593002289534
        ],
        "avg_attention": 0.6397107473264138,
        "combined_score": 0.3693371721724017,
        "disease_name": "melanoma",
        "clinical_relevance": "HIGH - Through B-cell protein network"
      },
      {
        "hops": 3,
        "path_type": "B_cell_protein_network",
        "mechanism": "CD19 interacts with SYK (B-cell protein), which is associated with this disease",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 2250,
            "name": "SYK",
            "type": "gene/protein",
            "role": "B_CELL_MARKER"
          },
          {
            "idx": 36621,
            "name": "mesothelioma",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.9093517065048218,
          0.5211631953716278
        ],
        "avg_attention": 0.6389120457073053,
        "combined_score": 0.3688760415776072,
        "disease_name": "mesothelioma",
        "clinical_relevance": "HIGH - Through B-cell protein network"
      },
      {
        "hops": 3,
        "path_type": "B_cell_protein_network",
        "mechanism": "CD19 interacts with CD79A (B-cell protein), which is associated with this disease",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 440,
            "name": "CD79A",
            "type": "gene/protein",
            "role": "B_CELL_MARKER"
          },
          {
            "idx": 35970,
            "name": "lymphoma",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.9040263593196869,
          0.5189841408282518
        ],
        "avg_attention": 0.6364105784644684,
        "combined_score": 0.36743181879158626,
        "disease_name": "lymphoma",
        "clinical_relevance": "HIGH - Through B-cell protein network"
      },
      {
        "hops": 3,
        "path_type": "B_cell_protein_network",
        "mechanism": "CD19 interacts with CD79A (B-cell protein), which is associated with this disease",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 440,
            "name": "CD79A",
            "type": "gene/protein",
            "role": "B_CELL_MARKER"
          },
          {
            "idx": 84157,
            "name": "diffuse large B-cell lymphoma of the central nervous system",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.9040263593196869,
          0.5182838086038828
        ],
        "avg_attention": 0.6361771343896786,
        "combined_score": 0.3672970397921657,
        "disease_name": "diffuse large B-cell lymphoma of the central nervous system",
        "clinical_relevance": "HIGH - Through B-cell protein network"
      },
      {
        "hops": 3,
        "path_type": "B_cell_protein_network",
        "mechanism": "CD19 interacts with CD79A (B-cell protein), which is associated with this disease",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 440,
            "name": "CD79A",
            "type": "gene/protein",
            "role": "B_CELL_MARKER"
          },
          {
            "idx": 84161,
            "name": "intravascular large B-cell lymphoma",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.9040263593196869,
          0.5165599845349789
        ],
        "avg_attention": 0.6356025263667107,
        "combined_score": 0.36696528969542663,
        "disease_name": "intravascular large B-cell lymphoma",
        "clinical_relevance": "HIGH - Through B-cell protein network"
      },
      {
        "hops": 3,
        "path_type": "B_cell_protein_network",
        "mechanism": "CD19 interacts with SYK (B-cell protein), which is associated with this disease",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 2250,
            "name": "SYK",
            "type": "gene/protein",
            "role": "B_CELL_MARKER"
          },
          {
            "idx": 30725,
            "name": "malignant mesothelioma (disease)",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.9093517065048218,
          0.5104788243770599
        ],
        "avg_attention": 0.635350588709116,
        "combined_score": 0.36681983342099533,
        "disease_name": "malignant mesothelioma (disease)",
        "clinical_relevance": "HIGH - Through B-cell protein network"
      },
      {
        "hops": 3,
        "path_type": "B_cell_protein_network",
        "mechanism": "CD19 interacts with CD79A (B-cell protein), which is associated with this disease",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 440,
            "name": "CD79A",
            "type": "gene/protein",
            "role": "B_CELL_MARKER"
          },
          {
            "idx": 84160,
            "name": "primary mediastinal large B-cell lymphoma",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.9040263593196869,
          0.5150868613272905
        ],
        "avg_attention": 0.6351114852974812,
        "combined_score": 0.36668178700192383,
        "disease_name": "primary mediastinal large B-cell lymphoma",
        "clinical_relevance": "HIGH - Through B-cell protein network"
      },
      {
        "hops": 3,
        "path_type": "B_cell_protein_network",
        "mechanism": "CD19 interacts with CD79A (B-cell protein), which is associated with this disease",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 440,
            "name": "CD79A",
            "type": "gene/protein",
            "role": "B_CELL_MARKER"
          },
          {
            "idx": 30447,
            "name": "lymphoma, non-Hodgkin, familial",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.9040263593196869,
          0.5128718856722116
        ],
        "avg_attention": 0.6343731600791216,
        "combined_score": 0.36625551473835444,
        "disease_name": "lymphoma, non-Hodgkin, familial",
        "clinical_relevance": "HIGH - Through B-cell protein network"
      },
      {
        "hops": 3,
        "path_type": "B_cell_protein_network",
        "mechanism": "CD19 interacts with CD79A (B-cell protein), which is associated with this disease",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 440,
            "name": "CD79A",
            "type": "gene/protein",
            "role": "B_CELL_MARKER"
          },
          {
            "idx": 84154,
            "name": "primary cutaneous diffuse large B-cell lymphoma, Leg type",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.9040263593196869,
          0.5118004577234387
        ],
        "avg_attention": 0.6340160174295306,
        "combined_score": 0.366049318333474,
        "disease_name": "primary cutaneous diffuse large B-cell lymphoma, Leg type",
        "clinical_relevance": "HIGH - Through B-cell protein network"
      },
      {
        "hops": 3,
        "path_type": "B_cell_protein_network",
        "mechanism": "CD19 interacts with BTK (B-cell protein), which is associated with this disease",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 337,
            "name": "BTK",
            "type": "gene/protein",
            "role": "B_CELL_MARKER"
          },
          {
            "idx": 35737,
            "name": "breast adenocarcinoma",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.8958995044231415,
          0.5199172832071781
        ],
        "avg_attention": 0.6340126742919286,
        "combined_score": 0.36604738817207955,
        "disease_name": "breast adenocarcinoma",
        "clinical_relevance": "HIGH - Through B-cell protein network"
      },
      {
        "hops": 3,
        "path_type": "B_cell_protein_network",
        "mechanism": "CD19 interacts with BTK (B-cell protein), which is associated with this disease",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 337,
            "name": "BTK",
            "type": "gene/protein",
            "role": "B_CELL_MARKER"
          },
          {
            "idx": 83766,
            "name": "short stature due to isolated growth hormone deficiency with X-linked hypogammaglobulinemia",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.8958995044231415,
          0.5192446783185005
        ],
        "avg_attention": 0.6337884726623694,
        "combined_score": 0.36591794530090077,
        "disease_name": "short stature due to isolated growth hormone deficiency with X-linked hypogammaglobulinemia",
        "clinical_relevance": "HIGH - Through B-cell protein network"
      },
      {
        "hops": 3,
        "path_type": "B_cell_protein_network",
        "mechanism": "CD19 interacts with CD79A (B-cell protein), which is associated with this disease",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 440,
            "name": "CD79A",
            "type": "gene/protein",
            "role": "B_CELL_MARKER"
          },
          {
            "idx": 36458,
            "name": "Langerhans cell histiocytosis",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.9040263593196869,
          0.5108242435380816
        ],
        "avg_attention": 0.6336906127010783,
        "combined_score": 0.36586144582590646,
        "disease_name": "Langerhans cell histiocytosis",
        "clinical_relevance": "HIGH - Through B-cell protein network"
      },
      {
        "hops": 3,
        "path_type": "B_cell_protein_network",
        "mechanism": "CD19 interacts with CD79A (B-cell protein), which is associated with this disease",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 440,
            "name": "CD79A",
            "type": "gene/protein",
            "role": "B_CELL_MARKER"
          },
          {
            "idx": 35650,
            "name": "non-Hodgkin lymphoma",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.9040263593196869,
          0.5103628877550364
        ],
        "avg_attention": 0.6335368274400631,
        "combined_score": 0.36577265786406193,
        "disease_name": "non-Hodgkin lymphoma",
        "clinical_relevance": "HIGH - Through B-cell protein network"
      },
      {
        "hops": 3,
        "path_type": "B_cell_protein_network",
        "mechanism": "CD19 interacts with CD79A (B-cell protein), which is associated with this disease",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 440,
            "name": "CD79A",
            "type": "gene/protein",
            "role": "B_CELL_MARKER"
          },
          {
            "idx": 84158,
            "name": "T-cell/histiocyte rich large B cell lymphoma",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.9040263593196869,
          0.5102125545963645
        ],
        "avg_attention": 0.6334867163871726,
        "combined_score": 0.3657437262341862,
        "disease_name": "T-cell/histiocyte rich large B cell lymphoma",
        "clinical_relevance": "HIGH - Through B-cell protein network"
      },
      {
        "hops": 3,
        "path_type": "B_cell_protein_network",
        "mechanism": "CD19 interacts with BTK (B-cell protein), which is associated with this disease",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 337,
            "name": "BTK",
            "type": "gene/protein",
            "role": "B_CELL_MARKER"
          },
          {
            "idx": 84244,
            "name": "undifferentiated carcinoma of the corpus uteri",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.8958995044231415,
          0.5148844700306654
        ],
        "avg_attention": 0.6323350698997577,
        "combined_score": 0.36507882282466597,
        "disease_name": "undifferentiated carcinoma of the corpus uteri",
        "clinical_relevance": "HIGH - Through B-cell protein network"
      },
      {
        "hops": 3,
        "path_type": "B_cell_protein_network",
        "mechanism": "CD19 interacts with BTK (B-cell protein), which is associated with this disease",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 337,
            "name": "BTK",
            "type": "gene/protein",
            "role": "B_CELL_MARKER"
          },
          {
            "idx": 32617,
            "name": "hereditary breast ovarian cancer syndrome",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.8958995044231415,
          0.5145896878093481
        ],
        "avg_attention": 0.6322368091593186,
        "combined_score": 0.3650220919597226,
        "disease_name": "hereditary breast ovarian cancer syndrome",
        "clinical_relevance": "HIGH - Through B-cell protein network"
      },
      {
        "hops": 3,
        "path_type": "B_cell_protein_network",
        "mechanism": "CD19 interacts with CD79A (B-cell protein), which is associated with this disease",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 440,
            "name": "CD79A",
            "type": "gene/protein",
            "role": "B_CELL_MARKER"
          },
          {
            "idx": 32531,
            "name": "mantle cell lymphoma",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.9040263593196869,
          0.5063098734244704
        ],
        "avg_attention": 0.6321858226632079,
        "combined_score": 0.3649926548924681,
        "disease_name": "mantle cell lymphoma",
        "clinical_relevance": "HIGH - Through B-cell protein network"
      },
      {
        "hops": 3,
        "path_type": "B_cell_protein_network",
        "mechanism": "CD19 interacts with CD79A (B-cell protein), which is associated with this disease",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 440,
            "name": "CD79A",
            "type": "gene/protein",
            "role": "B_CELL_MARKER"
          },
          {
            "idx": 35884,
            "name": "diffuse large B-cell lymphoma",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.9040263593196869,
          0.5060533420182765
        ],
        "avg_attention": 0.6321003121944765,
        "combined_score": 0.3649432854003275,
        "disease_name": "diffuse large B-cell lymphoma",
        "clinical_relevance": "HIGH - Through B-cell protein network"
      },
      {
        "hops": 3,
        "path_type": "B_cell_protein_network",
        "mechanism": "CD19 interacts with BTK (B-cell protein), which is associated with this disease",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 337,
            "name": "BTK",
            "type": "gene/protein",
            "role": "B_CELL_MARKER"
          },
          {
            "idx": 37338,
            "name": "lung large cell carcinoma",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.8958995044231415,
          0.5140565754845738
        ],
        "avg_attention": 0.6320591050510606,
        "combined_score": 0.3649194944449838,
        "disease_name": "lung large cell carcinoma",
        "clinical_relevance": "HIGH - Through B-cell protein network"
      },
      {
        "hops": 3,
        "path_type": "B_cell_protein_network",
        "mechanism": "CD19 interacts with BTK (B-cell protein), which is associated with this disease",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 337,
            "name": "BTK",
            "type": "gene/protein",
            "role": "B_CELL_MARKER"
          },
          {
            "idx": 30828,
            "name": "Bruton-type agammaglobulinemia",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.8958995044231415,
          0.5127518251538277
        ],
        "avg_attention": 0.6316241882741451,
        "combined_score": 0.3646683951267566,
        "disease_name": "Bruton-type agammaglobulinemia",
        "clinical_relevance": "HIGH - Through B-cell protein network"
      },
      {
        "hops": 3,
        "path_type": "B_cell_protein_network",
        "mechanism": "CD19 interacts with CD79A (B-cell protein), which is associated with this disease",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 440,
            "name": "CD79A",
            "type": "gene/protein",
            "role": "B_CELL_MARKER"
          },
          {
            "idx": 84155,
            "name": "Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.9040263593196869,
          0.5042648506350815
        ],
        "avg_attention": 0.6315041484000782,
        "combined_score": 0.36459909007315056,
        "disease_name": "Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly",
        "clinical_relevance": "HIGH - Through B-cell protein network"
      },
      {
        "hops": 3,
        "path_type": "B_cell_protein_network",
        "mechanism": "CD19 interacts with CD79A (B-cell protein), which is associated with this disease",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 440,
            "name": "CD79A",
            "type": "gene/protein",
            "role": "B_CELL_MARKER"
          },
          {
            "idx": 84156,
            "name": "plasmablastic lymphoma",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.9040263593196869,
          0.5038788339588791
        ],
        "avg_attention": 0.6313754761746774,
        "combined_score": 0.3645248011291782,
        "disease_name": "plasmablastic lymphoma",
        "clinical_relevance": "HIGH - Through B-cell protein network"
      },
      {
        "hops": 3,
        "path_type": "B_cell_protein_network",
        "mechanism": "CD19 interacts with BTK (B-cell protein), which is associated with this disease",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 337,
            "name": "BTK",
            "type": "gene/protein",
            "role": "B_CELL_MARKER"
          },
          {
            "idx": 38989,
            "name": "congenital agammaglobulinemia",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.8958995044231415,
          0.5116697289049625
        ],
        "avg_attention": 0.6312634895245234,
        "combined_score": 0.3644601456065661,
        "disease_name": "congenital agammaglobulinemia",
        "clinical_relevance": "HIGH - Through B-cell protein network"
      },
      {
        "hops": 3,
        "path_type": "B_cell_protein_network",
        "mechanism": "CD19 interacts with CD79A (B-cell protein), which is associated with this disease",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 440,
            "name": "CD79A",
            "type": "gene/protein",
            "role": "B_CELL_MARKER"
          },
          {
            "idx": 84159,
            "name": "ALK-positive large B-cell lymphoma",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.9040263593196869,
          0.502692878479138
        ],
        "avg_attention": 0.6309801576814303,
        "combined_score": 0.3642965638906863,
        "disease_name": "ALK-positive large B-cell lymphoma",
        "clinical_relevance": "HIGH - Through B-cell protein network"
      },
      {
        "hops": 3,
        "path_type": "B_cell_protein_network",
        "mechanism": "CD19 interacts with SYK (B-cell protein), which is associated with this disease",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 2250,
            "name": "SYK",
            "type": "gene/protein",
            "role": "B_CELL_MARKER"
          },
          {
            "idx": 36386,
            "name": "benign mesothelioma",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.9093517065048218,
          0.4966164925135672
        ],
        "avg_attention": 0.630729811421285,
        "combined_score": 0.36415202641000083,
        "disease_name": "benign mesothelioma",
        "clinical_relevance": "HIGH - Through B-cell protein network"
      },
      {
        "hops": 3,
        "path_type": "B_cell_protein_network",
        "mechanism": "CD19 interacts with BTK (B-cell protein), which is associated with this disease",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 337,
            "name": "BTK",
            "type": "gene/protein",
            "role": "B_CELL_MARKER"
          },
          {
            "idx": 94678,
            "name": "benign breast phyllodes tumor",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.8958995044231415,
          0.5095976619049907
        ],
        "avg_attention": 0.6305728005245328,
        "combined_score": 0.3640613761264952,
        "disease_name": "benign breast phyllodes tumor",
        "clinical_relevance": "HIGH - Through B-cell protein network"
      },
      {
        "hops": 3,
        "path_type": "B_cell_protein_network",
        "mechanism": "CD19 interacts with BTK (B-cell protein), which is associated with this disease",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 337,
            "name": "BTK",
            "type": "gene/protein",
            "role": "B_CELL_MARKER"
          },
          {
            "idx": 35771,
            "name": "breast neoplasm",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.8958995044231415,
          0.5089422715827823
        ],
        "avg_attention": 0.6303543370837966,
        "combined_score": 0.3639352462001781,
        "disease_name": "breast neoplasm",
        "clinical_relevance": "HIGH - Through B-cell protein network"
      },
      {
        "hops": 3,
        "path_type": "B_cell_protein_network",
        "mechanism": "CD19 interacts with BTK (B-cell protein), which is associated with this disease",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 337,
            "name": "BTK",
            "type": "gene/protein",
            "role": "B_CELL_MARKER"
          },
          {
            "idx": 30654,
            "name": "acute lymphoblastic/lymphocytic leukemia",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.8958995044231415,
          0.5087962886318564
        ],
        "avg_attention": 0.6303056761001548,
        "combined_score": 0.36390715176817345,
        "disease_name": "acute lymphoblastic/lymphocytic leukemia",
        "clinical_relevance": "HIGH - Through B-cell protein network"
      },
      {
        "hops": 3,
        "path_type": "B_cell_protein_network",
        "mechanism": "CD19 interacts with CD79A (B-cell protein), which is associated with this disease",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 440,
            "name": "CD79A",
            "type": "gene/protein",
            "role": "B_CELL_MARKER"
          },
          {
            "idx": 36425,
            "name": "primary central nervous system lymphoma",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.9040263593196869,
          0.5002249873214168
        ],
        "avg_attention": 0.6301575272955233,
        "combined_score": 0.3638216180159394,
        "disease_name": "primary central nervous system lymphoma",
        "clinical_relevance": "HIGH - Through B-cell protein network"
      },
      {
        "hops": 3,
        "path_type": "B_cell_protein_network",
        "mechanism": "CD19 interacts with CD79A (B-cell protein), which is associated with this disease",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 440,
            "name": "CD79A",
            "type": "gene/protein",
            "role": "B_CELL_MARKER"
          },
          {
            "idx": 37267,
            "name": "syndromic agammaglobulinemia",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.9040263593196869,
          0.5
        ],
        "avg_attention": 0.6300825315217177,
        "combined_score": 0.3637783191857446,
        "disease_name": "syndromic agammaglobulinemia",
        "clinical_relevance": "HIGH - Through B-cell protein network"
      },
      {
        "hops": 3,
        "path_type": "B_cell_protein_network",
        "mechanism": "CD19 interacts with BTK (B-cell protein), which is associated with this disease",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 337,
            "name": "BTK",
            "type": "gene/protein",
            "role": "B_CELL_MARKER"
          },
          {
            "idx": 28347,
            "name": "hereditary breast carcinoma",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.8958995044231415,
          0.5068918326869607
        ],
        "avg_attention": 0.6296708574518561,
        "combined_score": 0.3635406390506916,
        "disease_name": "hereditary breast carcinoma",
        "clinical_relevance": "HIGH - Through B-cell protein network"
      },
      {
        "hops": 3,
        "path_type": "B_cell_protein_network",
        "mechanism": "CD19 interacts with CD79A (B-cell protein), which is associated with this disease",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 440,
            "name": "CD79A",
            "type": "gene/protein",
            "role": "B_CELL_MARKER"
          },
          {
            "idx": 35651,
            "name": "B-cell neoplasm",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.9040263593196869,
          0.4982375878607854
        ],
        "avg_attention": 0.6294950608086461,
        "combined_score": 0.3634391428114117,
        "disease_name": "B-cell neoplasm",
        "clinical_relevance": "HIGH - Through B-cell protein network"
      },
      {
        "hops": 3,
        "path_type": "B_cell_protein_network",
        "mechanism": "CD19 interacts with CD79A (B-cell protein), which is associated with this disease",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 440,
            "name": "CD79A",
            "type": "gene/protein",
            "role": "B_CELL_MARKER"
          },
          {
            "idx": 27170,
            "name": "agammaglobulinemia",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.9040263593196869,
          0.496008959133178
        ],
        "avg_attention": 0.6287521845661104,
        "combined_score": 0.3630102430128091,
        "disease_name": "agammaglobulinemia",
        "clinical_relevance": "HIGH - Through B-cell protein network"
      },
      {
        "hops": 3,
        "path_type": "B_cell_protein_network",
        "mechanism": "CD19 interacts with BTK (B-cell protein), which is associated with this disease",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 337,
            "name": "BTK",
            "type": "gene/protein",
            "role": "B_CELL_MARKER"
          },
          {
            "idx": 36691,
            "name": "breast cancer",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.8958995044231415,
          0.5005330126732588
        ],
        "avg_attention": 0.6275512507806221,
        "combined_score": 0.3623168835684786,
        "disease_name": "breast cancer",
        "clinical_relevance": "HIGH - Through B-cell protein network"
      },
      {
        "hops": 3,
        "path_type": "B_cell_protein_network",
        "mechanism": "CD19 interacts with BTK (B-cell protein), which is associated with this disease",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 337,
            "name": "BTK",
            "type": "gene/protein",
            "role": "B_CELL_MARKER"
          },
          {
            "idx": 27249,
            "name": "isolated growth hormone deficiency",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.8958995044231415,
          0.5
        ],
        "avg_attention": 0.6273735798895359,
        "combined_score": 0.36221430523168274,
        "disease_name": "isolated growth hormone deficiency",
        "clinical_relevance": "HIGH - Through B-cell protein network"
      },
      {
        "hops": 3,
        "path_type": "B_cell_protein_network",
        "mechanism": "CD19 interacts with BTK (B-cell protein), which is associated with this disease",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 337,
            "name": "BTK",
            "type": "gene/protein",
            "role": "B_CELL_MARKER"
          },
          {
            "idx": 37334,
            "name": "breast carcinoma",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.8958995044231415,
          0.4969235663302243
        ],
        "avg_attention": 0.6263481019996107,
        "combined_score": 0.36162224529588644,
        "disease_name": "breast carcinoma",
        "clinical_relevance": "HIGH - Through B-cell protein network"
      },
      {
        "hops": 3,
        "path_type": "B_cell_protein_network",
        "mechanism": "CD19 interacts with BTK (B-cell protein), which is associated with this disease",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 337,
            "name": "BTK",
            "type": "gene/protein",
            "role": "B_CELL_MARKER"
          },
          {
            "idx": 84243,
            "name": "squamous cell carcinoma of the corpus uteri",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.8958995044231415,
          0.4932358143851161
        ],
        "avg_attention": 0.6251188513512412,
        "combined_score": 0.3609125371031488,
        "disease_name": "squamous cell carcinoma of the corpus uteri",
        "clinical_relevance": "HIGH - Through B-cell protein network"
      },
      {
        "hops": 3,
        "path_type": "B_cell_protein_network",
        "mechanism": "CD19 interacts with BTK (B-cell protein), which is associated with this disease",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 337,
            "name": "BTK",
            "type": "gene/protein",
            "role": "B_CELL_MARKER"
          },
          {
            "idx": 83868,
            "name": "Richter syndrome",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.8958995044231415,
          0.49041944183409214
        ],
        "avg_attention": 0.6241800605008999,
        "combined_score": 0.36037052595299146,
        "disease_name": "Richter syndrome",
        "clinical_relevance": "HIGH - Through B-cell protein network"
      },
      {
        "hops": 3,
        "path_type": "B_cell_protein_network",
        "mechanism": "CD19 interacts with PAX5 (B-cell protein), which is associated with this disease",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 309,
            "name": "PAX5",
            "type": "gene/protein",
            "role": "B_CELL_MARKER"
          },
          {
            "idx": 33621,
            "name": "acute lymphoblastic leukemia (disease)",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.7917563617229462,
          0.5117503674700856
        ],
        "avg_attention": 0.596575988146166,
        "combined_score": 0.34443330734825595,
        "disease_name": "acute lymphoblastic leukemia (disease)",
        "clinical_relevance": "HIGH - Through B-cell protein network"
      },
      {
        "hops": 3,
        "path_type": "B_cell_protein_network",
        "mechanism": "CD19 interacts with PAX5 (B-cell protein), which is associated with this disease",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 309,
            "name": "PAX5",
            "type": "gene/protein",
            "role": "B_CELL_MARKER"
          },
          {
            "idx": 35866,
            "name": "precursor lymphoblastic lymphoma/leukemia",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.7917563617229462,
          0.5098392004147172
        ],
        "avg_attention": 0.5959389324610432,
        "combined_score": 0.34406550307696154,
        "disease_name": "precursor lymphoblastic lymphoma/leukemia",
        "clinical_relevance": "HIGH - Through B-cell protein network"
      },
      {
        "hops": 3,
        "path_type": "B_cell_protein_network",
        "mechanism": "CD19 interacts with PAX5 (B-cell protein), which is associated with this disease",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 309,
            "name": "PAX5",
            "type": "gene/protein",
            "role": "B_CELL_MARKER"
          },
          {
            "idx": 28830,
            "name": "leukemia, lymphocytic, susceptibility to",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.7917563617229462,
          0.5012555319117382
        ],
        "avg_attention": 0.5930777096267169,
        "combined_score": 0.34241357530335176,
        "disease_name": "leukemia, lymphocytic, susceptibility to",
        "clinical_relevance": "HIGH - Through B-cell protein network"
      },
      {
        "hops": 3,
        "path_type": "B_cell_protein_network",
        "mechanism": "CD19 interacts with PAX5 (B-cell protein), which is associated with this disease",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 309,
            "name": "PAX5",
            "type": "gene/protein",
            "role": "B_CELL_MARKER"
          },
          {
            "idx": 30075,
            "name": "Burkitt lymphoma",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.7917563617229462,
          0.4991455393610522
        ],
        "avg_attention": 0.5923743787764882,
        "combined_score": 0.3420075070476428,
        "disease_name": "Burkitt lymphoma",
        "clinical_relevance": "HIGH - Through B-cell protein network"
      },
      {
        "hops": 3,
        "path_type": "B_cell_protein_network",
        "mechanism": "CD19 interacts with PAX5 (B-cell protein), which is associated with this disease",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 309,
            "name": "PAX5",
            "type": "gene/protein",
            "role": "B_CELL_MARKER"
          },
          {
            "idx": 35852,
            "name": "acute lymphoblastic leukemia",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.7917563617229462,
          0.4770771097391844
        ],
        "avg_attention": 0.585018235569199,
        "combined_score": 0.33776043578671694,
        "disease_name": "acute lymphoblastic leukemia",
        "clinical_relevance": "HIGH - Through B-cell protein network"
      }
    ],
    "B_cell_disease": [
      {
        "hops": 3,
        "path_type": "B_cell_disease",
        "mechanism": "CD19 protein protein with CD79A, implicated in diffuse large B-cell lymphoma of the central nervous system",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 440,
            "name": "CD79A",
            "type": "gene/protein",
            "role": "B_CELL_MARKER"
          },
          {
            "idx": 84157,
            "name": "diffuse large B-cell lymphoma of the central nervous system",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.9040263593196869,
          0.5182838086038828
        ],
        "avg_attention": 0.6361771343896786,
        "combined_score": 0.3672970397921657,
        "disease_name": "diffuse large B-cell lymphoma of the central nervous system",
        "clinical_relevance": "MEDIUM-HIGH - B-cell related disease"
      },
      {
        "hops": 3,
        "path_type": "B_cell_disease",
        "mechanism": "CD19 protein protein with CD79A, implicated in intravascular large B-cell lymphoma",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 440,
            "name": "CD79A",
            "type": "gene/protein",
            "role": "B_CELL_MARKER"
          },
          {
            "idx": 84161,
            "name": "intravascular large B-cell lymphoma",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.9040263593196869,
          0.5165599845349789
        ],
        "avg_attention": 0.6356025263667107,
        "combined_score": 0.36696528969542663,
        "disease_name": "intravascular large B-cell lymphoma",
        "clinical_relevance": "MEDIUM-HIGH - B-cell related disease"
      },
      {
        "hops": 3,
        "path_type": "B_cell_disease",
        "mechanism": "CD19 protein protein with CD79A, implicated in primary mediastinal large B-cell lymphoma",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 440,
            "name": "CD79A",
            "type": "gene/protein",
            "role": "B_CELL_MARKER"
          },
          {
            "idx": 84160,
            "name": "primary mediastinal large B-cell lymphoma",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.9040263593196869,
          0.5150868613272905
        ],
        "avg_attention": 0.6351114852974812,
        "combined_score": 0.36668178700192383,
        "disease_name": "primary mediastinal large B-cell lymphoma",
        "clinical_relevance": "MEDIUM-HIGH - B-cell related disease"
      },
      {
        "hops": 3,
        "path_type": "B_cell_disease",
        "mechanism": "CD19 protein protein with CD79A, implicated in primary cutaneous diffuse large B-cell lymphoma, Leg type",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 440,
            "name": "CD79A",
            "type": "gene/protein",
            "role": "B_CELL_MARKER"
          },
          {
            "idx": 84154,
            "name": "primary cutaneous diffuse large B-cell lymphoma, Leg type",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.9040263593196869,
          0.5118004577234387
        ],
        "avg_attention": 0.6340160174295306,
        "combined_score": 0.366049318333474,
        "disease_name": "primary cutaneous diffuse large B-cell lymphoma, Leg type",
        "clinical_relevance": "MEDIUM-HIGH - B-cell related disease"
      },
      {
        "hops": 3,
        "path_type": "B_cell_disease",
        "mechanism": "CD19 protein protein with CD79A, implicated in T-cell/histiocyte rich large B cell lymphoma",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 440,
            "name": "CD79A",
            "type": "gene/protein",
            "role": "B_CELL_MARKER"
          },
          {
            "idx": 84158,
            "name": "T-cell/histiocyte rich large B cell lymphoma",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.9040263593196869,
          0.5102125545963645
        ],
        "avg_attention": 0.6334867163871726,
        "combined_score": 0.3657437262341862,
        "disease_name": "T-cell/histiocyte rich large B cell lymphoma",
        "clinical_relevance": "MEDIUM-HIGH - B-cell related disease"
      },
      {
        "hops": 3,
        "path_type": "B_cell_disease",
        "mechanism": "CD19 protein protein with BTK, implicated in Bruton-type agammaglobulinemia",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 337,
            "name": "BTK",
            "type": "gene/protein",
            "role": "B_CELL_MARKER"
          },
          {
            "idx": 30828,
            "name": "Bruton-type agammaglobulinemia",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.8958995044231415,
          0.5127518251538277
        ],
        "avg_attention": 0.6316241882741451,
        "combined_score": 0.3646683951267566,
        "disease_name": "Bruton-type agammaglobulinemia",
        "clinical_relevance": "MEDIUM-HIGH - B-cell related disease"
      },
      {
        "hops": 3,
        "path_type": "B_cell_disease",
        "mechanism": "CD19 protein protein with CD79A, implicated in Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 440,
            "name": "CD79A",
            "type": "gene/protein",
            "role": "B_CELL_MARKER"
          },
          {
            "idx": 84155,
            "name": "Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.9040263593196869,
          0.5042648506350815
        ],
        "avg_attention": 0.6315041484000782,
        "combined_score": 0.36459909007315056,
        "disease_name": "Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly",
        "clinical_relevance": "MEDIUM-HIGH - B-cell related disease"
      },
      {
        "hops": 3,
        "path_type": "B_cell_disease",
        "mechanism": "CD19 protein protein with CD79A, implicated in plasmablastic lymphoma",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 440,
            "name": "CD79A",
            "type": "gene/protein",
            "role": "B_CELL_MARKER"
          },
          {
            "idx": 84156,
            "name": "plasmablastic lymphoma",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.9040263593196869,
          0.5038788339588791
        ],
        "avg_attention": 0.6313754761746774,
        "combined_score": 0.3645248011291782,
        "disease_name": "plasmablastic lymphoma",
        "clinical_relevance": "MEDIUM-HIGH - B-cell related disease"
      },
      {
        "hops": 3,
        "path_type": "B_cell_disease",
        "mechanism": "CD19 protein protein with BTK, implicated in congenital agammaglobulinemia",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 337,
            "name": "BTK",
            "type": "gene/protein",
            "role": "B_CELL_MARKER"
          },
          {
            "idx": 38989,
            "name": "congenital agammaglobulinemia",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.8958995044231415,
          0.5116697289049625
        ],
        "avg_attention": 0.6312634895245234,
        "combined_score": 0.3644601456065661,
        "disease_name": "congenital agammaglobulinemia",
        "clinical_relevance": "MEDIUM-HIGH - B-cell related disease"
      },
      {
        "hops": 3,
        "path_type": "B_cell_disease",
        "mechanism": "CD19 protein protein with CD79A, implicated in ALK-positive large B-cell lymphoma",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 440,
            "name": "CD79A",
            "type": "gene/protein",
            "role": "B_CELL_MARKER"
          },
          {
            "idx": 84159,
            "name": "ALK-positive large B-cell lymphoma",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.9040263593196869,
          0.502692878479138
        ],
        "avg_attention": 0.6309801576814303,
        "combined_score": 0.3642965638906863,
        "disease_name": "ALK-positive large B-cell lymphoma",
        "clinical_relevance": "MEDIUM-HIGH - B-cell related disease"
      },
      {
        "hops": 3,
        "path_type": "B_cell_disease",
        "mechanism": "CD19 protein protein with PAX5, implicated in leukemia, lymphocytic, susceptibility to",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 309,
            "name": "PAX5",
            "type": "gene/protein",
            "role": "B_CELL_MARKER"
          },
          {
            "idx": 28830,
            "name": "leukemia, lymphocytic, susceptibility to",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.7917563617229462,
          0.5012555319117382
        ],
        "avg_attention": 0.5930777096267169,
        "combined_score": 0.34241357530335176,
        "disease_name": "leukemia, lymphocytic, susceptibility to",
        "clinical_relevance": "MEDIUM-HIGH - B-cell related disease"
      }
    ],
    "CD19_direct_target": [
      {
        "hops": 2,
        "path_type": "CD19_direct_target",
        "mechanism": "Inebilizumab targets CD19, which is associated with this disease",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 32587,
            "name": "common variable immunodeficiency",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.5391860827803612
        ],
        "avg_attention": 0.5127036590129137,
        "combined_score": 0.3625362340271866,
        "disease_name": "common variable immunodeficiency",
        "clinical_relevance": "HIGH - Direct target-disease connection"
      },
      {
        "hops": 2,
        "path_type": "CD19_direct_target",
        "mechanism": "Inebilizumab targets CD19, which is associated with this disease",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 27188,
            "name": "immunodeficiency, common variable",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.5368110537528992
        ],
        "avg_attention": 0.5115161444991827,
        "combined_score": 0.36169653446176997,
        "disease_name": "immunodeficiency, common variable",
        "clinical_relevance": "HIGH - Direct target-disease connection"
      },
      {
        "hops": 2,
        "path_type": "CD19_direct_target",
        "mechanism": "Inebilizumab targets CD19, which is associated with this disease",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 27170,
            "name": "agammaglobulinemia",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.5138264540582895
        ],
        "avg_attention": 0.5000238446518779,
        "combined_score": 0.3535702513083116,
        "disease_name": "agammaglobulinemia",
        "clinical_relevance": "HIGH - Direct target-disease connection"
      },
      {
        "hops": 2,
        "path_type": "CD19_direct_target",
        "mechanism": "Inebilizumab targets CD19, which is associated with this disease",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 37267,
            "name": "syndromic agammaglobulinemia",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.5
        ],
        "avg_attention": 0.4931106176227331,
        "combined_score": 0.34868186159612125,
        "disease_name": "syndromic agammaglobulinemia",
        "clinical_relevance": "HIGH - Direct target-disease connection"
      }
    ]
  },
  "paths_by_relevance": {
    "HIGH": [
      {
        "hops": 3,
        "path_type": "B_cell_protein_network",
        "mechanism": "CD19 interacts with CD79A (B-cell protein), which is associated with this disease",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 440,
            "name": "CD79A",
            "type": "gene/protein",
            "role": "B_CELL_MARKER"
          },
          {
            "idx": 83796,
            "name": "lymphosarcoma",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.9040263593196869,
          0.5310772471129894
        ],
        "avg_attention": 0.6404416138927141,
        "combined_score": 0.3697591381811969,
        "disease_name": "lymphosarcoma",
        "clinical_relevance": "HIGH - Through B-cell protein network"
      },
      {
        "hops": 3,
        "path_type": "B_cell_protein_network",
        "mechanism": "CD19 interacts with SYK (B-cell protein), which is associated with this disease",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 2250,
            "name": "SYK",
            "type": "gene/protein",
            "role": "B_CELL_MARKER"
          },
          {
            "idx": 33653,
            "name": "melanoma",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.9093517065048218,
          0.5235593002289534
        ],
        "avg_attention": 0.6397107473264138,
        "combined_score": 0.3693371721724017,
        "disease_name": "melanoma",
        "clinical_relevance": "HIGH - Through B-cell protein network"
      },
      {
        "hops": 3,
        "path_type": "B_cell_protein_network",
        "mechanism": "CD19 interacts with SYK (B-cell protein), which is associated with this disease",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 2250,
            "name": "SYK",
            "type": "gene/protein",
            "role": "B_CELL_MARKER"
          },
          {
            "idx": 36621,
            "name": "mesothelioma",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.9093517065048218,
          0.5211631953716278
        ],
        "avg_attention": 0.6389120457073053,
        "combined_score": 0.3688760415776072,
        "disease_name": "mesothelioma",
        "clinical_relevance": "HIGH - Through B-cell protein network"
      },
      {
        "hops": 3,
        "path_type": "B_cell_protein_network",
        "mechanism": "CD19 interacts with CD79A (B-cell protein), which is associated with this disease",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 440,
            "name": "CD79A",
            "type": "gene/protein",
            "role": "B_CELL_MARKER"
          },
          {
            "idx": 35970,
            "name": "lymphoma",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.9040263593196869,
          0.5189841408282518
        ],
        "avg_attention": 0.6364105784644684,
        "combined_score": 0.36743181879158626,
        "disease_name": "lymphoma",
        "clinical_relevance": "HIGH - Through B-cell protein network"
      },
      {
        "hops": 3,
        "path_type": "B_cell_protein_network",
        "mechanism": "CD19 interacts with CD79A (B-cell protein), which is associated with this disease",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 440,
            "name": "CD79A",
            "type": "gene/protein",
            "role": "B_CELL_MARKER"
          },
          {
            "idx": 84157,
            "name": "diffuse large B-cell lymphoma of the central nervous system",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.9040263593196869,
          0.5182838086038828
        ],
        "avg_attention": 0.6361771343896786,
        "combined_score": 0.3672970397921657,
        "disease_name": "diffuse large B-cell lymphoma of the central nervous system",
        "clinical_relevance": "HIGH - Through B-cell protein network"
      },
      {
        "hops": 3,
        "path_type": "B_cell_protein_network",
        "mechanism": "CD19 interacts with CD79A (B-cell protein), which is associated with this disease",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 440,
            "name": "CD79A",
            "type": "gene/protein",
            "role": "B_CELL_MARKER"
          },
          {
            "idx": 84161,
            "name": "intravascular large B-cell lymphoma",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.9040263593196869,
          0.5165599845349789
        ],
        "avg_attention": 0.6356025263667107,
        "combined_score": 0.36696528969542663,
        "disease_name": "intravascular large B-cell lymphoma",
        "clinical_relevance": "HIGH - Through B-cell protein network"
      },
      {
        "hops": 3,
        "path_type": "B_cell_protein_network",
        "mechanism": "CD19 interacts with SYK (B-cell protein), which is associated with this disease",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 2250,
            "name": "SYK",
            "type": "gene/protein",
            "role": "B_CELL_MARKER"
          },
          {
            "idx": 30725,
            "name": "malignant mesothelioma (disease)",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.9093517065048218,
          0.5104788243770599
        ],
        "avg_attention": 0.635350588709116,
        "combined_score": 0.36681983342099533,
        "disease_name": "malignant mesothelioma (disease)",
        "clinical_relevance": "HIGH - Through B-cell protein network"
      },
      {
        "hops": 3,
        "path_type": "B_cell_protein_network",
        "mechanism": "CD19 interacts with CD79A (B-cell protein), which is associated with this disease",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 440,
            "name": "CD79A",
            "type": "gene/protein",
            "role": "B_CELL_MARKER"
          },
          {
            "idx": 84160,
            "name": "primary mediastinal large B-cell lymphoma",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.9040263593196869,
          0.5150868613272905
        ],
        "avg_attention": 0.6351114852974812,
        "combined_score": 0.36668178700192383,
        "disease_name": "primary mediastinal large B-cell lymphoma",
        "clinical_relevance": "HIGH - Through B-cell protein network"
      },
      {
        "hops": 3,
        "path_type": "B_cell_protein_network",
        "mechanism": "CD19 interacts with CD79A (B-cell protein), which is associated with this disease",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 440,
            "name": "CD79A",
            "type": "gene/protein",
            "role": "B_CELL_MARKER"
          },
          {
            "idx": 30447,
            "name": "lymphoma, non-Hodgkin, familial",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.9040263593196869,
          0.5128718856722116
        ],
        "avg_attention": 0.6343731600791216,
        "combined_score": 0.36625551473835444,
        "disease_name": "lymphoma, non-Hodgkin, familial",
        "clinical_relevance": "HIGH - Through B-cell protein network"
      },
      {
        "hops": 3,
        "path_type": "B_cell_protein_network",
        "mechanism": "CD19 interacts with CD79A (B-cell protein), which is associated with this disease",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 440,
            "name": "CD79A",
            "type": "gene/protein",
            "role": "B_CELL_MARKER"
          },
          {
            "idx": 84154,
            "name": "primary cutaneous diffuse large B-cell lymphoma, Leg type",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.9040263593196869,
          0.5118004577234387
        ],
        "avg_attention": 0.6340160174295306,
        "combined_score": 0.366049318333474,
        "disease_name": "primary cutaneous diffuse large B-cell lymphoma, Leg type",
        "clinical_relevance": "HIGH - Through B-cell protein network"
      },
      {
        "hops": 3,
        "path_type": "B_cell_protein_network",
        "mechanism": "CD19 interacts with BTK (B-cell protein), which is associated with this disease",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 337,
            "name": "BTK",
            "type": "gene/protein",
            "role": "B_CELL_MARKER"
          },
          {
            "idx": 35737,
            "name": "breast adenocarcinoma",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.8958995044231415,
          0.5199172832071781
        ],
        "avg_attention": 0.6340126742919286,
        "combined_score": 0.36604738817207955,
        "disease_name": "breast adenocarcinoma",
        "clinical_relevance": "HIGH - Through B-cell protein network"
      },
      {
        "hops": 3,
        "path_type": "B_cell_protein_network",
        "mechanism": "CD19 interacts with BTK (B-cell protein), which is associated with this disease",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 337,
            "name": "BTK",
            "type": "gene/protein",
            "role": "B_CELL_MARKER"
          },
          {
            "idx": 83766,
            "name": "short stature due to isolated growth hormone deficiency with X-linked hypogammaglobulinemia",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.8958995044231415,
          0.5192446783185005
        ],
        "avg_attention": 0.6337884726623694,
        "combined_score": 0.36591794530090077,
        "disease_name": "short stature due to isolated growth hormone deficiency with X-linked hypogammaglobulinemia",
        "clinical_relevance": "HIGH - Through B-cell protein network"
      },
      {
        "hops": 3,
        "path_type": "B_cell_protein_network",
        "mechanism": "CD19 interacts with CD79A (B-cell protein), which is associated with this disease",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 440,
            "name": "CD79A",
            "type": "gene/protein",
            "role": "B_CELL_MARKER"
          },
          {
            "idx": 36458,
            "name": "Langerhans cell histiocytosis",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.9040263593196869,
          0.5108242435380816
        ],
        "avg_attention": 0.6336906127010783,
        "combined_score": 0.36586144582590646,
        "disease_name": "Langerhans cell histiocytosis",
        "clinical_relevance": "HIGH - Through B-cell protein network"
      },
      {
        "hops": 3,
        "path_type": "B_cell_protein_network",
        "mechanism": "CD19 interacts with CD79A (B-cell protein), which is associated with this disease",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 440,
            "name": "CD79A",
            "type": "gene/protein",
            "role": "B_CELL_MARKER"
          },
          {
            "idx": 35650,
            "name": "non-Hodgkin lymphoma",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.9040263593196869,
          0.5103628877550364
        ],
        "avg_attention": 0.6335368274400631,
        "combined_score": 0.36577265786406193,
        "disease_name": "non-Hodgkin lymphoma",
        "clinical_relevance": "HIGH - Through B-cell protein network"
      },
      {
        "hops": 3,
        "path_type": "B_cell_protein_network",
        "mechanism": "CD19 interacts with CD79A (B-cell protein), which is associated with this disease",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 440,
            "name": "CD79A",
            "type": "gene/protein",
            "role": "B_CELL_MARKER"
          },
          {
            "idx": 84158,
            "name": "T-cell/histiocyte rich large B cell lymphoma",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.9040263593196869,
          0.5102125545963645
        ],
        "avg_attention": 0.6334867163871726,
        "combined_score": 0.3657437262341862,
        "disease_name": "T-cell/histiocyte rich large B cell lymphoma",
        "clinical_relevance": "HIGH - Through B-cell protein network"
      },
      {
        "hops": 3,
        "path_type": "B_cell_protein_network",
        "mechanism": "CD19 interacts with BTK (B-cell protein), which is associated with this disease",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 337,
            "name": "BTK",
            "type": "gene/protein",
            "role": "B_CELL_MARKER"
          },
          {
            "idx": 84244,
            "name": "undifferentiated carcinoma of the corpus uteri",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.8958995044231415,
          0.5148844700306654
        ],
        "avg_attention": 0.6323350698997577,
        "combined_score": 0.36507882282466597,
        "disease_name": "undifferentiated carcinoma of the corpus uteri",
        "clinical_relevance": "HIGH - Through B-cell protein network"
      },
      {
        "hops": 3,
        "path_type": "B_cell_protein_network",
        "mechanism": "CD19 interacts with BTK (B-cell protein), which is associated with this disease",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 337,
            "name": "BTK",
            "type": "gene/protein",
            "role": "B_CELL_MARKER"
          },
          {
            "idx": 32617,
            "name": "hereditary breast ovarian cancer syndrome",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.8958995044231415,
          0.5145896878093481
        ],
        "avg_attention": 0.6322368091593186,
        "combined_score": 0.3650220919597226,
        "disease_name": "hereditary breast ovarian cancer syndrome",
        "clinical_relevance": "HIGH - Through B-cell protein network"
      },
      {
        "hops": 3,
        "path_type": "B_cell_protein_network",
        "mechanism": "CD19 interacts with CD79A (B-cell protein), which is associated with this disease",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 440,
            "name": "CD79A",
            "type": "gene/protein",
            "role": "B_CELL_MARKER"
          },
          {
            "idx": 32531,
            "name": "mantle cell lymphoma",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.9040263593196869,
          0.5063098734244704
        ],
        "avg_attention": 0.6321858226632079,
        "combined_score": 0.3649926548924681,
        "disease_name": "mantle cell lymphoma",
        "clinical_relevance": "HIGH - Through B-cell protein network"
      },
      {
        "hops": 3,
        "path_type": "B_cell_protein_network",
        "mechanism": "CD19 interacts with CD79A (B-cell protein), which is associated with this disease",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 440,
            "name": "CD79A",
            "type": "gene/protein",
            "role": "B_CELL_MARKER"
          },
          {
            "idx": 35884,
            "name": "diffuse large B-cell lymphoma",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.9040263593196869,
          0.5060533420182765
        ],
        "avg_attention": 0.6321003121944765,
        "combined_score": 0.3649432854003275,
        "disease_name": "diffuse large B-cell lymphoma",
        "clinical_relevance": "HIGH - Through B-cell protein network"
      },
      {
        "hops": 3,
        "path_type": "B_cell_protein_network",
        "mechanism": "CD19 interacts with BTK (B-cell protein), which is associated with this disease",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 337,
            "name": "BTK",
            "type": "gene/protein",
            "role": "B_CELL_MARKER"
          },
          {
            "idx": 37338,
            "name": "lung large cell carcinoma",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.8958995044231415,
          0.5140565754845738
        ],
        "avg_attention": 0.6320591050510606,
        "combined_score": 0.3649194944449838,
        "disease_name": "lung large cell carcinoma",
        "clinical_relevance": "HIGH - Through B-cell protein network"
      },
      {
        "hops": 3,
        "path_type": "B_cell_protein_network",
        "mechanism": "CD19 interacts with BTK (B-cell protein), which is associated with this disease",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 337,
            "name": "BTK",
            "type": "gene/protein",
            "role": "B_CELL_MARKER"
          },
          {
            "idx": 30828,
            "name": "Bruton-type agammaglobulinemia",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.8958995044231415,
          0.5127518251538277
        ],
        "avg_attention": 0.6316241882741451,
        "combined_score": 0.3646683951267566,
        "disease_name": "Bruton-type agammaglobulinemia",
        "clinical_relevance": "HIGH - Through B-cell protein network"
      },
      {
        "hops": 3,
        "path_type": "B_cell_protein_network",
        "mechanism": "CD19 interacts with CD79A (B-cell protein), which is associated with this disease",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 440,
            "name": "CD79A",
            "type": "gene/protein",
            "role": "B_CELL_MARKER"
          },
          {
            "idx": 84155,
            "name": "Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.9040263593196869,
          0.5042648506350815
        ],
        "avg_attention": 0.6315041484000782,
        "combined_score": 0.36459909007315056,
        "disease_name": "Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly",
        "clinical_relevance": "HIGH - Through B-cell protein network"
      },
      {
        "hops": 3,
        "path_type": "B_cell_protein_network",
        "mechanism": "CD19 interacts with CD79A (B-cell protein), which is associated with this disease",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 440,
            "name": "CD79A",
            "type": "gene/protein",
            "role": "B_CELL_MARKER"
          },
          {
            "idx": 84156,
            "name": "plasmablastic lymphoma",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.9040263593196869,
          0.5038788339588791
        ],
        "avg_attention": 0.6313754761746774,
        "combined_score": 0.3645248011291782,
        "disease_name": "plasmablastic lymphoma",
        "clinical_relevance": "HIGH - Through B-cell protein network"
      },
      {
        "hops": 3,
        "path_type": "B_cell_protein_network",
        "mechanism": "CD19 interacts with BTK (B-cell protein), which is associated with this disease",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 337,
            "name": "BTK",
            "type": "gene/protein",
            "role": "B_CELL_MARKER"
          },
          {
            "idx": 38989,
            "name": "congenital agammaglobulinemia",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.8958995044231415,
          0.5116697289049625
        ],
        "avg_attention": 0.6312634895245234,
        "combined_score": 0.3644601456065661,
        "disease_name": "congenital agammaglobulinemia",
        "clinical_relevance": "HIGH - Through B-cell protein network"
      },
      {
        "hops": 3,
        "path_type": "B_cell_protein_network",
        "mechanism": "CD19 interacts with CD79A (B-cell protein), which is associated with this disease",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 440,
            "name": "CD79A",
            "type": "gene/protein",
            "role": "B_CELL_MARKER"
          },
          {
            "idx": 84159,
            "name": "ALK-positive large B-cell lymphoma",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.9040263593196869,
          0.502692878479138
        ],
        "avg_attention": 0.6309801576814303,
        "combined_score": 0.3642965638906863,
        "disease_name": "ALK-positive large B-cell lymphoma",
        "clinical_relevance": "HIGH - Through B-cell protein network"
      },
      {
        "hops": 3,
        "path_type": "B_cell_protein_network",
        "mechanism": "CD19 interacts with SYK (B-cell protein), which is associated with this disease",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 2250,
            "name": "SYK",
            "type": "gene/protein",
            "role": "B_CELL_MARKER"
          },
          {
            "idx": 36386,
            "name": "benign mesothelioma",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.9093517065048218,
          0.4966164925135672
        ],
        "avg_attention": 0.630729811421285,
        "combined_score": 0.36415202641000083,
        "disease_name": "benign mesothelioma",
        "clinical_relevance": "HIGH - Through B-cell protein network"
      },
      {
        "hops": 3,
        "path_type": "B_cell_protein_network",
        "mechanism": "CD19 interacts with BTK (B-cell protein), which is associated with this disease",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 337,
            "name": "BTK",
            "type": "gene/protein",
            "role": "B_CELL_MARKER"
          },
          {
            "idx": 94678,
            "name": "benign breast phyllodes tumor",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.8958995044231415,
          0.5095976619049907
        ],
        "avg_attention": 0.6305728005245328,
        "combined_score": 0.3640613761264952,
        "disease_name": "benign breast phyllodes tumor",
        "clinical_relevance": "HIGH - Through B-cell protein network"
      },
      {
        "hops": 3,
        "path_type": "B_cell_protein_network",
        "mechanism": "CD19 interacts with BTK (B-cell protein), which is associated with this disease",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 337,
            "name": "BTK",
            "type": "gene/protein",
            "role": "B_CELL_MARKER"
          },
          {
            "idx": 35771,
            "name": "breast neoplasm",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.8958995044231415,
          0.5089422715827823
        ],
        "avg_attention": 0.6303543370837966,
        "combined_score": 0.3639352462001781,
        "disease_name": "breast neoplasm",
        "clinical_relevance": "HIGH - Through B-cell protein network"
      },
      {
        "hops": 3,
        "path_type": "B_cell_protein_network",
        "mechanism": "CD19 interacts with BTK (B-cell protein), which is associated with this disease",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 337,
            "name": "BTK",
            "type": "gene/protein",
            "role": "B_CELL_MARKER"
          },
          {
            "idx": 30654,
            "name": "acute lymphoblastic/lymphocytic leukemia",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.8958995044231415,
          0.5087962886318564
        ],
        "avg_attention": 0.6303056761001548,
        "combined_score": 0.36390715176817345,
        "disease_name": "acute lymphoblastic/lymphocytic leukemia",
        "clinical_relevance": "HIGH - Through B-cell protein network"
      },
      {
        "hops": 3,
        "path_type": "B_cell_protein_network",
        "mechanism": "CD19 interacts with CD79A (B-cell protein), which is associated with this disease",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 440,
            "name": "CD79A",
            "type": "gene/protein",
            "role": "B_CELL_MARKER"
          },
          {
            "idx": 36425,
            "name": "primary central nervous system lymphoma",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.9040263593196869,
          0.5002249873214168
        ],
        "avg_attention": 0.6301575272955233,
        "combined_score": 0.3638216180159394,
        "disease_name": "primary central nervous system lymphoma",
        "clinical_relevance": "HIGH - Through B-cell protein network"
      },
      {
        "hops": 3,
        "path_type": "B_cell_protein_network",
        "mechanism": "CD19 interacts with CD79A (B-cell protein), which is associated with this disease",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 440,
            "name": "CD79A",
            "type": "gene/protein",
            "role": "B_CELL_MARKER"
          },
          {
            "idx": 37267,
            "name": "syndromic agammaglobulinemia",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.9040263593196869,
          0.5
        ],
        "avg_attention": 0.6300825315217177,
        "combined_score": 0.3637783191857446,
        "disease_name": "syndromic agammaglobulinemia",
        "clinical_relevance": "HIGH - Through B-cell protein network"
      },
      {
        "hops": 3,
        "path_type": "B_cell_protein_network",
        "mechanism": "CD19 interacts with BTK (B-cell protein), which is associated with this disease",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 337,
            "name": "BTK",
            "type": "gene/protein",
            "role": "B_CELL_MARKER"
          },
          {
            "idx": 28347,
            "name": "hereditary breast carcinoma",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.8958995044231415,
          0.5068918326869607
        ],
        "avg_attention": 0.6296708574518561,
        "combined_score": 0.3635406390506916,
        "disease_name": "hereditary breast carcinoma",
        "clinical_relevance": "HIGH - Through B-cell protein network"
      },
      {
        "hops": 3,
        "path_type": "B_cell_protein_network",
        "mechanism": "CD19 interacts with CD79A (B-cell protein), which is associated with this disease",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 440,
            "name": "CD79A",
            "type": "gene/protein",
            "role": "B_CELL_MARKER"
          },
          {
            "idx": 35651,
            "name": "B-cell neoplasm",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.9040263593196869,
          0.4982375878607854
        ],
        "avg_attention": 0.6294950608086461,
        "combined_score": 0.3634391428114117,
        "disease_name": "B-cell neoplasm",
        "clinical_relevance": "HIGH - Through B-cell protein network"
      },
      {
        "hops": 3,
        "path_type": "B_cell_protein_network",
        "mechanism": "CD19 interacts with CD79A (B-cell protein), which is associated with this disease",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 440,
            "name": "CD79A",
            "type": "gene/protein",
            "role": "B_CELL_MARKER"
          },
          {
            "idx": 27170,
            "name": "agammaglobulinemia",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.9040263593196869,
          0.496008959133178
        ],
        "avg_attention": 0.6287521845661104,
        "combined_score": 0.3630102430128091,
        "disease_name": "agammaglobulinemia",
        "clinical_relevance": "HIGH - Through B-cell protein network"
      },
      {
        "hops": 2,
        "path_type": "CD19_direct_target",
        "mechanism": "Inebilizumab targets CD19, which is associated with this disease",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 32587,
            "name": "common variable immunodeficiency",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.5391860827803612
        ],
        "avg_attention": 0.5127036590129137,
        "combined_score": 0.3625362340271866,
        "disease_name": "common variable immunodeficiency",
        "clinical_relevance": "HIGH - Direct target-disease connection"
      },
      {
        "hops": 3,
        "path_type": "B_cell_protein_network",
        "mechanism": "CD19 interacts with BTK (B-cell protein), which is associated with this disease",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 337,
            "name": "BTK",
            "type": "gene/protein",
            "role": "B_CELL_MARKER"
          },
          {
            "idx": 36691,
            "name": "breast cancer",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.8958995044231415,
          0.5005330126732588
        ],
        "avg_attention": 0.6275512507806221,
        "combined_score": 0.3623168835684786,
        "disease_name": "breast cancer",
        "clinical_relevance": "HIGH - Through B-cell protein network"
      },
      {
        "hops": 3,
        "path_type": "B_cell_protein_network",
        "mechanism": "CD19 interacts with BTK (B-cell protein), which is associated with this disease",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 337,
            "name": "BTK",
            "type": "gene/protein",
            "role": "B_CELL_MARKER"
          },
          {
            "idx": 27249,
            "name": "isolated growth hormone deficiency",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.8958995044231415,
          0.5
        ],
        "avg_attention": 0.6273735798895359,
        "combined_score": 0.36221430523168274,
        "disease_name": "isolated growth hormone deficiency",
        "clinical_relevance": "HIGH - Through B-cell protein network"
      },
      {
        "hops": 2,
        "path_type": "CD19_direct_target",
        "mechanism": "Inebilizumab targets CD19, which is associated with this disease",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 27188,
            "name": "immunodeficiency, common variable",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.5368110537528992
        ],
        "avg_attention": 0.5115161444991827,
        "combined_score": 0.36169653446176997,
        "disease_name": "immunodeficiency, common variable",
        "clinical_relevance": "HIGH - Direct target-disease connection"
      },
      {
        "hops": 3,
        "path_type": "B_cell_protein_network",
        "mechanism": "CD19 interacts with BTK (B-cell protein), which is associated with this disease",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 337,
            "name": "BTK",
            "type": "gene/protein",
            "role": "B_CELL_MARKER"
          },
          {
            "idx": 37334,
            "name": "breast carcinoma",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.8958995044231415,
          0.4969235663302243
        ],
        "avg_attention": 0.6263481019996107,
        "combined_score": 0.36162224529588644,
        "disease_name": "breast carcinoma",
        "clinical_relevance": "HIGH - Through B-cell protein network"
      },
      {
        "hops": 3,
        "path_type": "B_cell_protein_network",
        "mechanism": "CD19 interacts with BTK (B-cell protein), which is associated with this disease",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 337,
            "name": "BTK",
            "type": "gene/protein",
            "role": "B_CELL_MARKER"
          },
          {
            "idx": 84243,
            "name": "squamous cell carcinoma of the corpus uteri",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.8958995044231415,
          0.4932358143851161
        ],
        "avg_attention": 0.6251188513512412,
        "combined_score": 0.3609125371031488,
        "disease_name": "squamous cell carcinoma of the corpus uteri",
        "clinical_relevance": "HIGH - Through B-cell protein network"
      },
      {
        "hops": 3,
        "path_type": "B_cell_protein_network",
        "mechanism": "CD19 interacts with BTK (B-cell protein), which is associated with this disease",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 337,
            "name": "BTK",
            "type": "gene/protein",
            "role": "B_CELL_MARKER"
          },
          {
            "idx": 83868,
            "name": "Richter syndrome",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.8958995044231415,
          0.49041944183409214
        ],
        "avg_attention": 0.6241800605008999,
        "combined_score": 0.36037052595299146,
        "disease_name": "Richter syndrome",
        "clinical_relevance": "HIGH - Through B-cell protein network"
      },
      {
        "hops": 2,
        "path_type": "CD19_direct_target",
        "mechanism": "Inebilizumab targets CD19, which is associated with this disease",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 27170,
            "name": "agammaglobulinemia",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.5138264540582895
        ],
        "avg_attention": 0.5000238446518779,
        "combined_score": 0.3535702513083116,
        "disease_name": "agammaglobulinemia",
        "clinical_relevance": "HIGH - Direct target-disease connection"
      },
      {
        "hops": 2,
        "path_type": "CD19_direct_target",
        "mechanism": "Inebilizumab targets CD19, which is associated with this disease",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 37267,
            "name": "syndromic agammaglobulinemia",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.5
        ],
        "avg_attention": 0.4931106176227331,
        "combined_score": 0.34868186159612125,
        "disease_name": "syndromic agammaglobulinemia",
        "clinical_relevance": "HIGH - Direct target-disease connection"
      },
      {
        "hops": 3,
        "path_type": "B_cell_protein_network",
        "mechanism": "CD19 interacts with PAX5 (B-cell protein), which is associated with this disease",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 309,
            "name": "PAX5",
            "type": "gene/protein",
            "role": "B_CELL_MARKER"
          },
          {
            "idx": 33621,
            "name": "acute lymphoblastic leukemia (disease)",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.7917563617229462,
          0.5117503674700856
        ],
        "avg_attention": 0.596575988146166,
        "combined_score": 0.34443330734825595,
        "disease_name": "acute lymphoblastic leukemia (disease)",
        "clinical_relevance": "HIGH - Through B-cell protein network"
      },
      {
        "hops": 3,
        "path_type": "B_cell_protein_network",
        "mechanism": "CD19 interacts with PAX5 (B-cell protein), which is associated with this disease",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 309,
            "name": "PAX5",
            "type": "gene/protein",
            "role": "B_CELL_MARKER"
          },
          {
            "idx": 35866,
            "name": "precursor lymphoblastic lymphoma/leukemia",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.7917563617229462,
          0.5098392004147172
        ],
        "avg_attention": 0.5959389324610432,
        "combined_score": 0.34406550307696154,
        "disease_name": "precursor lymphoblastic lymphoma/leukemia",
        "clinical_relevance": "HIGH - Through B-cell protein network"
      },
      {
        "hops": 3,
        "path_type": "B_cell_protein_network",
        "mechanism": "CD19 interacts with PAX5 (B-cell protein), which is associated with this disease",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 309,
            "name": "PAX5",
            "type": "gene/protein",
            "role": "B_CELL_MARKER"
          },
          {
            "idx": 28830,
            "name": "leukemia, lymphocytic, susceptibility to",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.7917563617229462,
          0.5012555319117382
        ],
        "avg_attention": 0.5930777096267169,
        "combined_score": 0.34241357530335176,
        "disease_name": "leukemia, lymphocytic, susceptibility to",
        "clinical_relevance": "HIGH - Through B-cell protein network"
      },
      {
        "hops": 3,
        "path_type": "B_cell_protein_network",
        "mechanism": "CD19 interacts with PAX5 (B-cell protein), which is associated with this disease",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 309,
            "name": "PAX5",
            "type": "gene/protein",
            "role": "B_CELL_MARKER"
          },
          {
            "idx": 30075,
            "name": "Burkitt lymphoma",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.7917563617229462,
          0.4991455393610522
        ],
        "avg_attention": 0.5923743787764882,
        "combined_score": 0.3420075070476428,
        "disease_name": "Burkitt lymphoma",
        "clinical_relevance": "HIGH - Through B-cell protein network"
      },
      {
        "hops": 3,
        "path_type": "B_cell_protein_network",
        "mechanism": "CD19 interacts with PAX5 (B-cell protein), which is associated with this disease",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 309,
            "name": "PAX5",
            "type": "gene/protein",
            "role": "B_CELL_MARKER"
          },
          {
            "idx": 35852,
            "name": "acute lymphoblastic leukemia",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.7917563617229462,
          0.4770771097391844
        ],
        "avg_attention": 0.585018235569199,
        "combined_score": 0.33776043578671694,
        "disease_name": "acute lymphoblastic leukemia",
        "clinical_relevance": "HIGH - Through B-cell protein network"
      }
    ],
    "MEDIUM-HIGH": [
      {
        "hops": 3,
        "path_type": "B_cell_disease",
        "mechanism": "CD19 protein protein with CD79A, implicated in diffuse large B-cell lymphoma of the central nervous system",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 440,
            "name": "CD79A",
            "type": "gene/protein",
            "role": "B_CELL_MARKER"
          },
          {
            "idx": 84157,
            "name": "diffuse large B-cell lymphoma of the central nervous system",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.9040263593196869,
          0.5182838086038828
        ],
        "avg_attention": 0.6361771343896786,
        "combined_score": 0.3672970397921657,
        "disease_name": "diffuse large B-cell lymphoma of the central nervous system",
        "clinical_relevance": "MEDIUM-HIGH - B-cell related disease"
      },
      {
        "hops": 3,
        "path_type": "B_cell_disease",
        "mechanism": "CD19 protein protein with CD79A, implicated in intravascular large B-cell lymphoma",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 440,
            "name": "CD79A",
            "type": "gene/protein",
            "role": "B_CELL_MARKER"
          },
          {
            "idx": 84161,
            "name": "intravascular large B-cell lymphoma",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.9040263593196869,
          0.5165599845349789
        ],
        "avg_attention": 0.6356025263667107,
        "combined_score": 0.36696528969542663,
        "disease_name": "intravascular large B-cell lymphoma",
        "clinical_relevance": "MEDIUM-HIGH - B-cell related disease"
      },
      {
        "hops": 3,
        "path_type": "B_cell_disease",
        "mechanism": "CD19 protein protein with CD79A, implicated in primary mediastinal large B-cell lymphoma",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 440,
            "name": "CD79A",
            "type": "gene/protein",
            "role": "B_CELL_MARKER"
          },
          {
            "idx": 84160,
            "name": "primary mediastinal large B-cell lymphoma",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.9040263593196869,
          0.5150868613272905
        ],
        "avg_attention": 0.6351114852974812,
        "combined_score": 0.36668178700192383,
        "disease_name": "primary mediastinal large B-cell lymphoma",
        "clinical_relevance": "MEDIUM-HIGH - B-cell related disease"
      },
      {
        "hops": 3,
        "path_type": "B_cell_disease",
        "mechanism": "CD19 protein protein with CD79A, implicated in primary cutaneous diffuse large B-cell lymphoma, Leg type",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 440,
            "name": "CD79A",
            "type": "gene/protein",
            "role": "B_CELL_MARKER"
          },
          {
            "idx": 84154,
            "name": "primary cutaneous diffuse large B-cell lymphoma, Leg type",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.9040263593196869,
          0.5118004577234387
        ],
        "avg_attention": 0.6340160174295306,
        "combined_score": 0.366049318333474,
        "disease_name": "primary cutaneous diffuse large B-cell lymphoma, Leg type",
        "clinical_relevance": "MEDIUM-HIGH - B-cell related disease"
      },
      {
        "hops": 3,
        "path_type": "B_cell_disease",
        "mechanism": "CD19 protein protein with CD79A, implicated in T-cell/histiocyte rich large B cell lymphoma",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 440,
            "name": "CD79A",
            "type": "gene/protein",
            "role": "B_CELL_MARKER"
          },
          {
            "idx": 84158,
            "name": "T-cell/histiocyte rich large B cell lymphoma",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.9040263593196869,
          0.5102125545963645
        ],
        "avg_attention": 0.6334867163871726,
        "combined_score": 0.3657437262341862,
        "disease_name": "T-cell/histiocyte rich large B cell lymphoma",
        "clinical_relevance": "MEDIUM-HIGH - B-cell related disease"
      },
      {
        "hops": 3,
        "path_type": "B_cell_disease",
        "mechanism": "CD19 protein protein with BTK, implicated in Bruton-type agammaglobulinemia",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 337,
            "name": "BTK",
            "type": "gene/protein",
            "role": "B_CELL_MARKER"
          },
          {
            "idx": 30828,
            "name": "Bruton-type agammaglobulinemia",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.8958995044231415,
          0.5127518251538277
        ],
        "avg_attention": 0.6316241882741451,
        "combined_score": 0.3646683951267566,
        "disease_name": "Bruton-type agammaglobulinemia",
        "clinical_relevance": "MEDIUM-HIGH - B-cell related disease"
      },
      {
        "hops": 3,
        "path_type": "B_cell_disease",
        "mechanism": "CD19 protein protein with CD79A, implicated in Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 440,
            "name": "CD79A",
            "type": "gene/protein",
            "role": "B_CELL_MARKER"
          },
          {
            "idx": 84155,
            "name": "Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.9040263593196869,
          0.5042648506350815
        ],
        "avg_attention": 0.6315041484000782,
        "combined_score": 0.36459909007315056,
        "disease_name": "Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly",
        "clinical_relevance": "MEDIUM-HIGH - B-cell related disease"
      },
      {
        "hops": 3,
        "path_type": "B_cell_disease",
        "mechanism": "CD19 protein protein with CD79A, implicated in plasmablastic lymphoma",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 440,
            "name": "CD79A",
            "type": "gene/protein",
            "role": "B_CELL_MARKER"
          },
          {
            "idx": 84156,
            "name": "plasmablastic lymphoma",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.9040263593196869,
          0.5038788339588791
        ],
        "avg_attention": 0.6313754761746774,
        "combined_score": 0.3645248011291782,
        "disease_name": "plasmablastic lymphoma",
        "clinical_relevance": "MEDIUM-HIGH - B-cell related disease"
      },
      {
        "hops": 3,
        "path_type": "B_cell_disease",
        "mechanism": "CD19 protein protein with BTK, implicated in congenital agammaglobulinemia",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 337,
            "name": "BTK",
            "type": "gene/protein",
            "role": "B_CELL_MARKER"
          },
          {
            "idx": 38989,
            "name": "congenital agammaglobulinemia",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.8958995044231415,
          0.5116697289049625
        ],
        "avg_attention": 0.6312634895245234,
        "combined_score": 0.3644601456065661,
        "disease_name": "congenital agammaglobulinemia",
        "clinical_relevance": "MEDIUM-HIGH - B-cell related disease"
      },
      {
        "hops": 3,
        "path_type": "B_cell_disease",
        "mechanism": "CD19 protein protein with CD79A, implicated in ALK-positive large B-cell lymphoma",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 440,
            "name": "CD79A",
            "type": "gene/protein",
            "role": "B_CELL_MARKER"
          },
          {
            "idx": 84159,
            "name": "ALK-positive large B-cell lymphoma",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.9040263593196869,
          0.502692878479138
        ],
        "avg_attention": 0.6309801576814303,
        "combined_score": 0.3642965638906863,
        "disease_name": "ALK-positive large B-cell lymphoma",
        "clinical_relevance": "MEDIUM-HIGH - B-cell related disease"
      },
      {
        "hops": 3,
        "path_type": "B_cell_disease",
        "mechanism": "CD19 protein protein with PAX5, implicated in leukemia, lymphocytic, susceptibility to",
        "nodes": [
          {
            "idx": 19645,
            "name": "Inebilizumab",
            "type": "drug"
          },
          {
            "idx": 6067,
            "name": "CD19",
            "type": "gene/protein",
            "role": "PRIMARY_TARGET"
          },
          {
            "idx": 309,
            "name": "PAX5",
            "type": "gene/protein",
            "role": "B_CELL_MARKER"
          },
          {
            "idx": 28830,
            "name": "leukemia, lymphocytic, susceptibility to",
            "type": "disease"
          }
        ],
        "attention_scores": [
          0.48622123524546623,
          0.7917563617229462,
          0.5012555319117382
        ],
        "avg_attention": 0.5930777096267169,
        "combined_score": 0.34241357530335176,
        "disease_name": "leukemia, lymphocytic, susceptibility to",
        "clinical_relevance": "MEDIUM-HIGH - B-cell related disease"
      }
    ]
  }
}